[go: up one dir, main page]

US20020172656A1 - Cleansing compositions - Google Patents

Cleansing compositions Download PDF

Info

Publication number
US20020172656A1
US20020172656A1 US09/738,375 US73837500A US2002172656A1 US 20020172656 A1 US20020172656 A1 US 20020172656A1 US 73837500 A US73837500 A US 73837500A US 2002172656 A1 US2002172656 A1 US 2002172656A1
Authority
US
United States
Prior art keywords
cleansing
alkyl
skin
alkenyl
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US09/738,375
Inventor
Kimberly Biedermann
Jeffrey Morgan
Karl Wei
Mark Sine
Cheyne Thomas
David Tarantino
Christopher Irwin
Christopher Putman
Peter Beerse
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US09/738,375 priority Critical patent/US20020172656A1/en
Publication of US20020172656A1 publication Critical patent/US20020172656A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D17/00Detergent materials or soaps characterised by their shape or physical properties
    • C11D17/04Detergent materials or soaps characterised by their shape or physical properties combined with or containing other objects
    • C11D17/049Cleaning or scouring pads; Wipes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208Tissues; Wipes; Patches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/442Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/10Washing or bathing preparations
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • C11D1/88Ampholytes; Electroneutral compounds
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • C11D1/88Ampholytes; Electroneutral compounds
    • C11D1/90Betaines
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • C11D1/88Ampholytes; Electroneutral compounds
    • C11D1/92Sulfobetaines ; Sulfitobetaines
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • C11D1/88Ampholytes; Electroneutral compounds
    • C11D1/94Mixtures with anionic, cationic or non-ionic compounds
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/02Inorganic compounds ; Elemental compounds
    • C11D3/04Water-soluble compounds
    • C11D3/042Acids
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/20Organic compounds containing oxygen
    • C11D3/2075Carboxylic acids-salts thereof
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/20Organic compounds containing oxygen
    • C11D3/2075Carboxylic acids-salts thereof
    • C11D3/2082Polycarboxylic acids-salts thereof
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/20Organic compounds containing oxygen
    • C11D3/2075Carboxylic acids-salts thereof
    • C11D3/2086Hydroxy carboxylic acids-salts thereof
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/26Organic compounds containing nitrogen
    • C11D3/28Heterocyclic compounds containing nitrogen in the ring
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/26Organic compounds containing nitrogen
    • C11D3/33Amino carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/37Polymers
    • C11D3/3746Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • C11D3/3757(Co)polymerised carboxylic acids, -anhydrides, -esters in solid and liquid compositions
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/48Medical, disinfecting agents, disinfecting, antibacterial, germicidal or antimicrobial compositions
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • C11D1/66Non-ionic compounds
    • C11D1/75Amino oxides
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • C11D1/66Non-ionic compounds
    • C11D1/755Sulfoxides
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • C11D1/66Non-ionic compounds
    • C11D1/79Phosphine oxides

Definitions

  • the present invention relates to cleansing compositions comprising an amphoteric surfactant in combination with 2-pyrrolidone-5 carboxylic acid, wherein the composition provides immediate and residual antimicrobial activity on the applied areas of the skin.
  • the present invention also relates to corresponding articles of manufacture and methods of cleansing the skin using the cleansing compositions of the present invention.
  • Rhinoviruses are members of the picornavirus family. As such they are referred to as “naked viruses” since they lack an outer envelope. Such picornaviruses are known to be difficult to inactivate by commonly used means like quaternary ammonium compounds.
  • Rhinovirus infections are spread from person to person by means of virus-contaminated respiratory secretions. Evidence suggests that the primary mode of transmission is via direct contact, as opposed to inhalation of airborne viral particles. It has been demonstrated that ill persons have a propensity to contaminate their hands and environmental objects. Rhinovirus has been recovered from 40 to 90% of hands of persons experiencing colds and from 6 to 15% of diverse objects. Rhinovirus exhibits good survival on many environmental surfaces for hours after contamination, and infection is readily transmitted by finger-to-finger contact and by finger to contaminated environmental surface if the newly contaminated finger is then used to rub an eye or touch the nasal mucosa.
  • Gram positive bacteria are often established as permanent microcolonies on the surface and outermost layers of mammalian skin. Such bacteria play an important role in preventing the colonization of other more harmful bacteria and fungi.
  • Transient bacteria are not part of the normal resident flora of the skin but can be deposited when airborne contaminated material lands on the skin or when contaminated material is brought into physical contact with the skin.
  • Transient bacteria can include gram positive and Gram negative bacteria, including gram positive pathogens such as Staphylococcus aureus, Streptococcus pyogenes and Clostridium botulinum, and gram negative pathogens such as Salmonella, Escherichia coli, Klebsiella, Haemophilus, Pseudomonas aeruginosa, Proteus and Shigella dysenteriae.
  • Gram negative bacteria are generally distinguished from Gram positive by an additional protective cell membrane which generally results in the gram negative bacteria being less susceptible to topical antibacterial actives.
  • compositions and products which provide immediate and residual anti-viral and/or antibacterial efficacy, as well as improved residual antifungal efficacy.
  • compositions and products which provide improved immediate anti-viral (e.g., anti-rhinoviral) activity, and antibacterial activity in water based systems (i.e., non-alcohol).
  • improved immediate anti-viral e.g., anti-rhinoviral
  • antibacterial activity in water based systems (i.e., non-alcohol).
  • compositions and products which exhibit improved antifungal efficacy.
  • compositions of the present invention can be formulated to provide improved mildness to the skin and improved antibacterial, antiviral, and/or antifungal activity, wherein the compositions contain 2-pyrrolidone-5 carboxylic acid in combination with an amphoteric surfactant, which combination is deposited on the skin during application. It has been found that the 2-pyrrolidone-5 carboxylic acid component functions as a proton donating agent when used in combination with the amphoteric surfactant, wherein the proton donating effect of this particular acid provides immediate and residual antiviral, antibacterial, and/or antifungal activity on the applied areas of the skin.
  • the present invention relates to cleansing compositions, comprising from about 0.05% to about 10%, by weight of the composition, of an amphoteric surfactant; from about 0.1% to about 10%, by weight of the composition, of 2-pyrrolidone-5 carboxylic acid; and from about 3% to about 99.89%, by weight of the composition, of an aqueous component.
  • the cleansing compositions of the present invention have a pH in the range of from about 2.0 to about 5.5.
  • the present invention also relates to articles of manufacture and methods of cleansing the skin comprising the disclosed compositions.
  • the cleansing compositions of the present invention are highly effective in providing an improved germ reduction on the skin, are mild to the skin and can be used without additional available water.
  • safety and effective amount means an amount of a compound or composition sufficient to significantly induce a positive benefit, preferably an antimicrobial benefit, but low enough to avoid serious side effects, i.e., to provide a reasonable benefit to risk ratio, within the scope of sound judgment of the skilled artisan.
  • the cleansing composition of the present invention comprise the following essential components. These components are selected so that the efficacy and optional mildness requirements hereinafter defined for the compositions herein are met. The selection of each component is necessarily dependent on the selection of each of the other components. If a harsh surfactant is utilized, then a mildness agent may have to be utilized. Guidelines for the selection of the individual components are provided herein.
  • the cleansing compositions of the present invention comprise from about 0.01% to about 40%, preferably from about 0.01 % to about 20%, more preferably from about 0.05% to about 10%, and most preferably from about 0.05% to about 10%, by weight of the cleansing composition, of an amphoteric surfactant.
  • Amphoteric surfactants useful in the present invention are those having the following general formulae (I) (II), (III), (IV), (V) or mixtures thereof:
  • R 1 is an alkyl alkenyl, aryl, or hydroxyalkyl radical of from about 8 to about 22 carbon atoms, optionally interrupted with up to about 10 ethylene oxide moieties and/or 1 glyceryl moiety
  • R 2 and R 3 are individually selected from alkyl and monohydroxyalkyl groups containing from about 1 to about 3 carbon atoms
  • R 4 is alkylene, or hydroxyalkylene of from about 1 to about 4 carbon atoms
  • Z 1 is a radical selected from carboxylate, sulfonate, sulfate, phosphate, or phosphonate
  • x is 0 or 1
  • n is from about 1 to about 6
  • m is 0 or 1.
  • R 1 is an alkyl, alkenyl, or hydroxyalkyl radical of from 11 to 17 carbon atoms
  • R 2 and R 3 are individually selected from alkyl groups containing of from 1 to 3 carbon atoms
  • R 4 is alkylene or hydroxyalkylene of from 1 to 2 carbon atoms
  • Z 1 is a radical selected from carboxylate, sulfonate
  • x is 0 or 1
  • n is 1 to 3
  • m is 0 or 1.
  • R 5 is C 8 -C 22 alkyl, alkenyl, aryl, or hydroxyalkyl, preferably C 8 -C 22,
  • R 6 is hydrogen or CH 2 CO 2 M 1
  • R 7 is CH 2 CH 2 OH or CH 2 CH 2 OCH 2 CH 2 COOM 1
  • R 8 is hydrogen, CH 2 CH 2 OH, or CH 2 CH 2 OCH 2 CH 2 COOM 1
  • Z 2 is CO 2 M 1 or CH 2 CO 2 M 1
  • y is 2 or 3, preferably 2
  • M 1 is hydrogen or a cation, such as alkali metal, alkaline earth metal, ammonium, alkanol ammonium, sulfate, sulfonate, phosphate, or phosphonate.
  • a is a number from 1 to 4
  • R 9 is C 8 -C 22 alkyl, alkenyl, aryl, hydroxyalkyl or alkylamidoalkyls
  • M 2 is hydrogen, alkali metal, alkaline earth metal, ammonium or alkanolammonium.
  • R 10 or R 12 is methyl; ethyl, or hydroxyethyl, and R 11 is C 8 -C 22 alkyl, alkenyl, or aryl, or CH 3 (CH 2 ) p CONH(CH 2 ) q wherein p is 8-22 and q is 1-6.
  • R 10 and R 12 are methyl, R 11 is C 10-18 alkyl, alkenyl, p is 11-17, and q is 1-3.
  • amphoteric surfactants useful in the cleansing compositions having general formula (I) are amide betaines, amide sulfo betaines, alkyl betaines, alkenyl betaines, sultaines (sulfo betaines), and imidazolinium betaines.
  • amphoteric surfactants particularly useful are high alkyl betaines, such as coco dimethyl carboxymethyl betaine, cocamnidopropyl betaine under the trade name of TEGO BETAINE, coco betaine, lauryl betaine under the trade name REWOTERIC AM DML-35, lauryl amidopropyl betaine, oleyl betaine, lauryl dimethyl carboxymethyl betaine, lauryl dimethyl alpha-carboxyethyl betaine, cetyl dimethyl carboxymethyl betaine, lauryl bis-(2-hydroxyethyl) carboxymethyl betaine, stearyl bis-(2-hydroxypropyl) carboxymethyl betaine, oleyl dimethyl gamma-carboxypropyl betaine, lauryl bis-(2-hydroxypropyl) alpha-carboxyethyl betaine, cocamnidopropyl hydroxy sultaine (sulfobetaine), lauryl sultaine (lauryl sultaine
  • amphoteric surfactants useful in the cleansing compositions having general formula (II) are marketed under the trade name MIRANOL and are understood to comprise a complex mixture of species, and can exist in protonated and non-protonated species depending upon pH with respect to species that can have a hydrogen at R 6 .
  • the imidazolinium amphoteric surfactant hereof can be derived via an imidazolinium intermediate.
  • Preferred amphoteric surfactants of formula (II) are monocarboxylates and dicarboxylates. Examples of these materials include cocoamphocarboxypropionate, cocoamphocarboxypropionic acid, cocoamphocarboxyglycinate (alternately referred to as cocoamphodiacetate), and cocoamphoacetate.
  • Specific commercial products providing the imidazolinium derivative component of the present compositions include those sold under the trade names MIRANOL C2M CONC. N.P., MIRANOL C2M CONC. O.P., MIRANOL C2M SF, MIRANOL CM SPECIAL (Miranol, Inc.); ALKATERIC 2CIP (Alkaril Chemicals); cocoamphocarboxy propionate under the trade name NIKKOL AM-101, AMPHOTERGE W-2 (Lonza, Inc.); MONATERIC CDX-38, MONATERIC CSH-32 (Mona Industries); REWOTERIC AM-2C (Rewo Chemical Group); and SCHEROTERIC MS-2 (Scher Chemicals).
  • MIRANOL C2M CONC. N.P. MIRANOL C2M CONC. O.P.
  • MIRANOL C2M SF MIRANOL CM SPECIAL
  • ALKATERIC 2CIP Alkaril Chemicals
  • cocoamphocarboxy propionate under the trade
  • amphoteric surfactants useful in the cleansing compositions having general formulae (III) and (IV) include n-alkylaminopropionates and n-alkyliminodipropionates. Such materials are sold under the trade name DERIPHAT by Henkel and MIRATAINE by Miranol, Inc. Specific examples include N-lauryl-beta-amino propionic acid or salts thereof, and N-lauryl-beta-imino-dipropionic acid or salts thereof.
  • amphoteric surfactants useful in the cleansing compositions having general formula (V) are commonly known as amine oxides. Also useful are tertiary phosphine oxides and dialkyl sulfoxides. Mixtures of the above amphoteric surfactants can also be used.
  • amphoteric surfactants are amine oxides.
  • amine oxides particularly useful in the cleansing compositions are cocamine oxide, lauramine oxide under the trade name AMMONYX LO, and stearamidopropylamine oxide under the trade name VAROX 1770.
  • the cleansing compositions of the present invention comprise 2-pyrrolidone-5 carboxylic acid as a proton donating agent at concentrations ranging from about 0.1% to about 20%, preferably from about 0.1% to about 10%, more preferably from about 0.5% to about 8%, and most preferably from about 1% to about 5%, by weight of the composition.
  • proton donating agent refers to the 2-pyrrolidone-5 carboxylic acid component of the cleansing compositions that is horrtile applied topically to the skin and that results in undissociated acid on the applied area of the skin after application.
  • This particular proton donating agent remains at least partially undissociated in the neat composition and when the compositions are diluted during washing and rinsing.
  • This particular proton donating agent can be added directly to the cleansing composition in the acid form or can be formed by adding the conjugate base of the desired acid and a sufficient amount of a separate acid strong enough to form the undissociated acid from the base.
  • the pH of the cleansing compositions of the present invention must be adjusted to a sufficiently low level in order to either form or deposit substantial undissociated acid on the skin.
  • the pH of the compositions should be adjusted and preferably buffered to range from about 2.0 to about 5.5, preferably from about 2.5 to about 5.0 and more preferably from about 2.5 to about 4.5.
  • 2-pyrrolidone-5 carboxylic acid as the selected proton donating agent in the compositions of the present invention is milder to the skin and causes less stinging than many other acids that are likewise suitable for topical application to the skin.
  • the cleansing compositions described herein additionally comprise an aqueous component.
  • aqueous component refers to any material consisting essentially of, or predominantly of water, water soluble alcohol(s) such as ethanol, propanol or isopropanol, and mixtures thereof.
  • the aqueous component can optionally contain one or more water-soluble emollients including, but not limited to, lower molecular weight aliphatic diols such as propylene glycol and butylene glycol; polyols such as glycerine and sorbitol; and polyoxyethylene polymers such as polyethylene glycol 200.
  • water-soluble emollients including, but not limited to, lower molecular weight aliphatic diols such as propylene glycol and butylene glycol; polyols such as glycerine and sorbitol; and polyoxyethylene polymers such as polyethylene glycol 200.
  • the aqueous component is preferably water which is deionized, distilled or purified.
  • Preferred cleansing compositions comprise from about 3% to about 99.89%, preferably from about 5% to about 98%, more preferably from about 10% to about 97.5%, and most preferably from about 38% to about 95.99% , by weight of the aqueous component.
  • the cleansing compositions of the present invention may further comprise an antibacterial active at concentrations ranging from about 0.001% to about 5%, preferably from about 0.05% to about 1%, more preferably from about 0.05% to about 0.5%, even more preferably from about 0.1% to about 0.25%, by weight of the cleansing composition.
  • concentrations ranging from about 0.001% to about 5%, preferably from about 0.05% to about 1%, more preferably from about 0.05% to about 0.5%, even more preferably from about 0.1% to about 0.25%, by weight of the cleansing composition.
  • the exact amount of antibacterial active to be used in the compositions will depend upon factors such as the particular antimicrobial active utilized since actives vary in potency.
  • non-cationic antimicrobial agents which are useful in the compositions of the present invention:
  • PCMX Para-chloro-meta-xylenol
  • Another class of antibacterial agents that are useful in the compositions of the present invention are the so-called “natural” antibacterial actives, referred to as natural essential oils. These actives derive their names from their natural occurrence in plants.
  • natural essential oil antibacterial actives include oils of anise, lemon, orange, rosemary, wintergreen, thyme, lavender, cloves, hops, tea tree, citronella, wheat, barley, lemongrass, cedar leaf, cedarwood, cinnamon, fleagrass, geranium, sandalwood, violet, cranberry, eucalyptus, vervain, peppermint, gum benzoin, basil, fennel, fir, balsam, menthol, ocmea origanum, Hydastis carradensis, Berberidaceae daceae, Ratanhiae and Curcuma longa.
  • Also included in this class of natural essential oils are the key chemical components of the plant oils which have been found to provide the antimicrobial benefit. These chemicals include, but are not limited to anethol, catechole, camphene, carvacol, eugenol, eucalyptol, ferulic acid, farnesol, hinokitiol, tropolone, limonene, menthol, methyl salicylate, thymol, terpineol, verbenone, berberine, ratanhiae extract, caryophellene oxide, citronellic acid, curcumin, nerolidol and geraniol.
  • anethol catechole, camphene, carvacol, eugenol, eucalyptol, ferulic acid, farnesol, hinokitiol, tropolone, limonene, menthol, methyl salicylate, thymol, terpineol, verb
  • antimicrobial actives include antibacterial metal salts.
  • This class generally includes salts of metals in groups 3b-7b, 8 and 3a-5a, and specifically are the salts of aluminum, zirconium, zinc, silver, gold, copper, lanthanum, tin, mercury, bismuth, selenium, strontium, scandium, yttrium, cerium, praseodymiun, neodymium, promethum, samarium, europium, gadolinium, terbium, dysprosium, holmium, erbium, thulium, ytterbium, lutetium and mixtures thereof.
  • Preferred optional antimicrobial agents for use herein are benzalkonium chloride, benzethonium chloride, triclosan, triclocarban, octopirox, Para-chloro-meta-xylenol (PCMX), zinc pyrithione (ZPT), natural essential oils and their key ingredients, and mixtures thereof.
  • the most preferred antimicrobial active for optional use in the compositions of the present invention is Benzalkonium Chloride.
  • optional ingredients can be added to enhance the mildness to the skin.
  • These optional ingredients include cationic and nonionic polymers, co-surfactants, moisturizers and mixtures thereof.
  • Polymers useful herein include polyethylene glycols, polypropylene glycols, hydrolyzed silk proteins, hydrolyzed milk proteins, hydrolyzed keratin proteins, guar hydroxypropyltrimonium chloride, polyquats, silicone polymers and mixtures thereof.
  • the mildness enhancing polymers comprise from about 0.1% to about 1%, preferably from about 0.2% to about 1.0%, and more preferably from about 0.2% to about 0.6%, by weight of the cleansing wipe composition, of the composition.
  • Co-surfactants useful herein include nonionic surfactants such as the Genapol® 24 series of ethoxylated alcohols, POE(20) sorbitan monooleate (Tween® 80), polyethylene glycol cocoate and Pluronic® propylene oxide/ethylene oxide block polymers, and amphoteric surfactants such as alkyl betaines, alkyl sultaines, alkyl amphoacetates, alkyl amphodiacetates, alkyl amphopropionates, and alkyl amphodipropionates.
  • the mildness enhancing co-surfacants comprise from about 20% to about 70%, preferably from about 20% to about 50%, by weight of the amphotericsurfactant, of the cleansing composition.
  • lipid skin moisturizing agents which provide a moisturizing benefit to the user of the cleansing when the lipophilic skin moisturizing agent is deposited to the user's skin.
  • lipophilic skin moisturizing agents are used, they are employed at a level of about 0.1% to about 30%, preferably from about 0.2% to about 10%, most preferably from about 0.5% to about 5% by weight of the composition.
  • the lipophilic skin moisturizing agent can desirably be defined in terms of its solubility parameter, as defined by Vaughan in Cosmetics and Toiletries, Vol. 103, p. 47-69, October 1988.
  • a lipophilic skin moisturizing agent having a Vaughan solubility Parameter (VSP) from 5 to 10, preferably from 5.5 to 9 is suitable for use in the cleansing compositions herein.
  • VSP Vaughan solubility Parameter
  • the lipophilic skin conditioning agent is selected from the group consisting of hydrocarbon oils and waxes, silicones, fatty acid derivatives, cholesterol, cholesterol derivatives, di- and tri-glycerides, vegetable oils, vegetable oil derivatives, liquid nondigestible oils such as those described in U.S. Pat. No. 3,600,186 to Mattson; Issued Aug. 17, 1971 and U.S. Pat. Nos. 4,005,195 and 4,005,196 to Jandacek et al; both issued Jan.
  • Hydrocarbon oils and waxes Some examples are petrolatum, mineral oil microcrystalline waxes, polyalkenes (e.g. hydrogenated and nonhydrogenated polybutene and polydecene), paraffins, cerasin, ozokerite, polyethylene and perhydrosqualene. Blends of petrolatum and hydrogenated and nonhydrogenated high molecular weight polybutenes wherein the ratio of petrolatum to polybutene ranges from about 90:10 to about 40:60 are also suitable for use as the lipid skin moisturizing agent in the compositions herein.
  • petrolatum mineral oil microcrystalline waxes
  • polyalkenes e.g. hydrogenated and nonhydrogenated polybutene and polydecene
  • paraffins e.g. hydrogenated and nonhydrogenated polybutene and polydecene
  • cerasin e.g. hydrogenated and nonhydrogenated polybutene and polydecene
  • paraffins e.g. hydrogenated and nonhydr
  • Silicone Oils Some examples are dimethicone copolyol, dimethylpolysiloxane, diethyl-polysiloxane, high molecular weight dimethicone, mixed C1-C30 alkyl polysiloxane, phenyl dimethicone, dimethiconol, and mixtures thereof. More preferred are non-volatile silicones selected from dimethicone, dimethiconol, mixed C1-C30 alkyl polysiloxane, and mixtures thereof. Nonlimiting examples of silicones useful herein are described in U.S. Pat. No. 5,011,681, to Ciotti et al., issued Apr. 30, 1991, which is incorporated by reference.
  • Di- and tri-glycerides Some examples are castor oil, soy bean oil, derivatized soybean oils such as maleated soy bean oil, safflower oil, cotton seed oil, corn oil, walnut oil, peanut oil, olive oil, cod liver oil, almond oil, avocado oil, palm oil and sesame oil, vegetable oils and vegetable oil derivatives; coconut oil and derivatized coconut oil, cottonseed oil and derivatized cottonseed oil, jojoba oil, cocoa butter, and the like.
  • soy bean oil soy bean oil, derivatized soybean oils such as maleated soy bean oil, safflower oil, cotton seed oil, corn oil, walnut oil, peanut oil, olive oil, cod liver oil, almond oil, avocado oil, palm oil and sesame oil, vegetable oils and vegetable oil derivatives
  • coconut oil and derivatized coconut oil, cottonseed oil and derivatized cottonseed oil jojoba oil, cocoa butter, and the like.
  • Acetoglyceride esters are used and an example is acetylated monoglycerides.
  • Lanolin and its derivatives are preferred and some examples are lanolin, lanolin oil, lanolin wax, lanolin alcohols, lanolin fatty acids, isopropyl lanolate, acetylated lanolin, acetylated lanolin alcohols, lanolin alcohol linoleate, lanolin alcohol riconoleate.
  • the lipophilic skin conditioning agent is comprised of lipids selected from the group consisting: petrolatum, blends of petrolatum and high molecular weight polybutene, mineral oil, liquid nondigestible oils (e.g. liquid cottonseed sucrose octaesters) or blends of liquid digestible or nondigestible oils with solid polyol polyesters (e.g.
  • sucrose octaesters prepared from C22 fatty acids wherein the ratio of liquid digestible or nondigestible oil to solid polyol polyester ranges from about 96:4 to about 80:20, hydrogenated or nonhydrogenated polybutene, microcrystalline wax, polyalkene, paraffin, cerasin, ozokerite, polyethylene, perhydrosqualene; dimethicones, alkyl siloxane, polymethylsiloxane, methylphenylpolysiloxane and mixtures thereof.
  • the ratio of petrolatum to the other selected lipids is preferably from about 10:1 to about 1:2, more preferably from about 5:1 to about 1:1.
  • degreasing and/or detackifying agents in an effective amount to reduce the greasy feel or stickiness associated with the lipophilic skin moisturizers.
  • degreasing agent means an agent which prevents, reduces and/or eliminates the greasy or heavy skin feel typically associated with lipophilic materials.
  • detackifying agent means an agent which prevents, reduces and/or eliminates the sticky or tacky geeling typically associated with ingredients such as humectants.
  • Degreasing or detackifying agents suitable for use in the present invention are selected from the group consisting of select silicones, wax materials soluble in the alcoholic antiseptic and having a melting point greater than about 20° C., powders, fluorochemicals and mixtures thereof.
  • Nonvolatile silicone oils are volatile and non-volatile silicone oils.
  • nonvolatile as used herein means that the silicone has a boiling point of at least about 260° C., preferably at least about 275° C., more preferably at least about 300° C. Such materials exhibit very low or no significant vapor pressure at ambient conditions.
  • volatile as used herein mean that the silicone has a boiling point of from about 99° C. to about 260° C.
  • Volatile silicones suitable for use in the present invention are disclosed in U.S. Pat. No. 4,781,917, issued to Luebbe et al., Nov. 1, 1988 and U.S. Pat. No. 5,759,529 to LeGrow et al., issued Jun. 2, 1998, both of which are herein incorporated by reference in their entirety. Additionally, a description of various volatile silicones materials is found in Todd et al., “Volatile Silicone Fluids for Cosmetics”, Cosmetics and Toiletries, 91:27-32 (1976). Preferred silicones have surface tensions of less than about 35 dynes, more preferably less than about 30 dynes, most preferably less than about 25 dynes. Particularly preferred volatile silicone oils are selected from the group consisting of cyclic volatile silicones corresponding to the formula:
  • n is from about 3 to about 7; and linear volatile silicones corresponding to the formula:
  • Linear volatile silicones generally have a viscosity of less than about 5 centistokes at 25.degree. C., whereas the cyclic silicones have viscosities of less than about 10 centistokes at 25.degree. C.
  • Highly preferred examples of volatile silicone oils include cyclomethicones of varying viscosities, e.g., Dow Corning 200, Dow Corning 244, Dow Corning 245, Dow Corning 344, and Dow Corning 345, (commercially available from Dow Corning Corp.); SF-1204 and SF-1202 Silicone Fluids (commercially available from G.E.
  • volatile silicones comprise at least about or greater than about 3% to about 10%, more preferably from about 4% to about 8%, and most preferably from about 6% to about 8% by weight of the present invention.
  • nonvolatile silicones such as fluid silicones and gum silicones.
  • the molecular weight and viscosity of the particular selected silicone will determine whether it is a gum or a fluid.
  • silicone fluid denotes a silicone with viscosities ranging from about 5 to about 600,000 centistokes, most preferably from about 350 to about 100,000 centistokes, at 25° C.
  • silicone gum denotes silicones with mass molecular weights of from about 200,000 to about 1,000,000 and with viscosities greater than about 600,000 centistokes.
  • the non-volatile silicones of the present invention preferably have a viscosity of at least about 15,000 centipoise, more preferably at least 25,000 centipoise.
  • Suitable non-volatile silicones include polysiloxanes and other modified silicones. Polysiloxanes and other modified silicones are described in U.S. Pat. Nos. 5,650,144 and 5,840,288, both of which are herein incorporated by reference in their entirety. Examples of suitable polysiloxanes and modified silicones include, but are not limited to, polyalkylsiloxanes, polyarylsiloxanes, polyalkylarylsiloxanes, polyestersiloxanes, polyethersiloxane copolymers, polyfluorosiloxanes, polyaminosiloxanes, and mixtures thereof. Preferred non-volatile polysiloxanes are polydimethylsiloxane having viscosities of from about 5 to about 100,000 centistokes at 25° C.
  • Silicone fluid and gum mixtures or blends can also be used. Silicone gum and fluid blends are disclosed in U.S. Pat. No. 4,906,459, Cobb et al., issued Mar. 6, 1990; U.S. Pat. No. 4,788,006, Bolich, Jr. et al., issued Nov. 29, 1988; U.S. Pat. No. 4,741,855, Grote et al., issued May 3, 1988; U.S. Pat. No. 4,728,457, Fieler et al., issued Mar. 1, 1988; U.S. Pat. No. 4,704,272, Oh et al., issued Nov. 3, 1987; and U.S. Pat. No. 2,826,551, Geen, issued Mar. 11, 1958; U.S. Pat. No. 5,154,849, Visscher et al., issued Oct. 13, 1992, all of which are herein incorporated by reference in their entirety.
  • non-volatile silicones comprise from about 0.01% to about 5%, preferably from about 0.1% to about 2%, more preferably from about 0. 1% to about 1% by weight of the present invention.
  • Silicone elastomers are also useful as degreasing agents in the present invention. Suitable silicone elastomers are illustrated in U.S. Pat. No. 5,654,362, herein incorporated by reference in its entirety. Examples of suitable elastomers include, but are not limited to, dimethicone crosspolymer, dimethicone/vinyldimethicone corsspolymer, polysilicone-11 and mixtures thereof. Such elastomers can be used alone or with volatile or nonvolatile solvents. Examples of suitable solvents include, but are not limited to, volatile silicones, volatile alcohols, volatile esters, volatile hydrocarbons, and mixtures thereof.
  • the silicone elastomers are crosslinked and preferably have a weight average molecular weight greater than about 100,000.
  • Preferred for use herein are elastomer/solvent blends having an elastomer to solvent ratio of from about 1:100 to about 1:1, more preferably from about 1:30 to about 1:5.
  • the silicone elastomer blend has a viscosity of from about 50,000 centipoise to about 400,000 centipoise, more preferably from about 100,000 centipoise to about 300,000 centipoise.
  • silicone elastomer blends include cyclomethicone and dimethicone crosspolymer blend (Dow Coming®9040 silicone elastomer); cyclomethicone and dimethicone/vinyldimethicone cross polymer blend (SFE 839 elastomer dispersion available from GE); octamethylcyclotetrasiloxane and polysilicone-11 blend (Gransil GCM available from Shin Etsu); and mixtures thereof.
  • SFE 839 elastomer dispersion available from GE
  • octamethylcyclotetrasiloxane and polysilicone-11 blend Gnsil GCM available from Shin Etsu
  • Preferred herein is the cyclomethicone and dimethicone/vinyldimethicone cross polymer blend.
  • the silicone elastomer preferably comprises from about 0.01% to about 5%, preferably from about 0.1% to about 2%.
  • silicone elastomer or gum blends preferably comprise from about 0.1% to about 10%, preferably from about 1% to about 10%, most preferably from about 4% to about 10% by weight of the composition.
  • Wax materials used herein preferably have melting points of at least about or greater than about 20° C., more preferably at least about or greater than about 25° C., and still more preferably at least about or greater than 32° C., and most preferably at least about or greater than about 35° C.
  • the wax materials are preferably soluble in the alcohol antiseptic.
  • the phrase “soluble in the alcohol antiseptic,” as used herein, means the wax materials is soluble in the alcohol antiseptic, at 25° C., at a concentration of 0.1%, preferably 0.2%, more preferably 0.4% by weight, and most preferably soluble at 1.0% by weight.
  • suitable wax materials include, but are not limited to, dimethicone copolyols having a weight average molecular weight greater than about 1000 such as Biowax®.(supplied by Biosil), polyoxyethylene glycols having weight average molecular weight greater than about 500 such as Carbowax (supplied by Union Carbide), and mixtures thereof. Preferred for use herein is Biowax® 754.
  • polyoxyethylene glycols having weight average molecular weight greater than about 500, preferably from about 1000 to about 10,000, more preferably from about 1400 to about 6000. Most preferred is PEG-32 (Carbowax 1450).
  • the above wax materials preferably comprise from about 0.1% to about 10%, preferably from about 0.1% to about 5%, most preferably from about 0.4% to about 2% by weight of the composition.
  • Powder ingredients which may be compounded in the composition of the present invention include inorganic powder such as gums, chalk, Fuller's earth, talc, kaolin, iron oxide, mica, sericite, muscovite, phlogopite, synthetic mica, lepidolite, biotite, lithia mica, vermiculite, magnesium carbonate, calcium carbonate, aluminum silicate, starch, smectite clays, alkyl and/or trialkyl aryl ammonium smectites, chemically modified magnesium aluminum silicate, organically modified montmorillonite clay, hydrated aluminum silicate, fumed silica, aluminum starch octenyl succinate barium silicate, calcium silicate, magnesium silicate, strontium silicate, metal tungstate, magnesium, silica alumina, zeolite, barium sulfate, calcined calcium sulfate (calcined g)
  • the powders of the present invention have a particle size such that the average chord length of the powder particles range from about 0.01 microns to about 100 microns, preferably from about 0.1 microns to about 50 microns, more preferably from about 1 micron to about 20 microns.
  • the powders of the present invention are spherical or platelet in shape for smooth skin feel.
  • the powders can by amorphous or irregular shaped for a draggy skin feel.
  • powders preferably comprise from about 0.01% to about 10%, preferably from about 0.1% to about 10%, more preferably from about 0.1% to about 5%, most preferably from about 0.4% to about 2% by weight of the composition.
  • fluorochemicals include fluorotelemers, and perfluoropolyethers, some examples of which are described in Cosmetics & Toiletries, Using Fluorinated Compounds in Topical Preparations, Vol. 111, pages 47-62, (October 1996) which description is incorporated herein by reference. More specific examples of such liquid carriers include, but are not limited to, perfluoropolymethyl isopropyl ethers, perfluoropolypropylethers, acrylamide fluorinated telomer or mixtures thereof. Other more specific examples include, but are not limited to, the polyperfluoroisopropyl ethers available from Dupont Performance Chemicals under the trade name Fluortress ® PFPE oils.
  • powders preferably comprise from about 0.01% to about 10%, preferably from about 0.1% to about 2% by weight of the composition.
  • composition comprises three or more lipophilic skin moisturizing agents, two of said lipophilic skin moisturizing agents can also function as a thickening agent, or degreasing or detackifying agent.
  • a stabilizer may also be included at a level ranging from about 0.1% to about 10%, preferably from about 0.1% to about 8%, more preferably from about 0.1% to about 5% by weight of the cleansing composition.
  • the stabilizer is used to form a crystalline stabilizing network in the liquid cleansing composition that prevents the lipophilic skin moisturizer agent droplets from coalescing and phase splitting in the product.
  • the network exhibits time dependent recovery of viscosity after shearing (e.g., thixotropy).
  • the stabilizers used herein are not surfactants.
  • the stabilizers provide improved shelf and stress stability.
  • Some preferred hydroxyl-containing stabilizers include 12-hydroxystearic acid, 9,10-dihydroxystearic acid, tri-9,10-dihydroxystearin and tri-12-hydroxystearin (hydrogenated castor oil is mostly tri-12-hydroxystearin).
  • Tri-12-hydroxystearin is most preferred for use in the compositions herein.
  • these crystalline, hydroxyl-containing stabilizers are utilized in the cleansing compositions herein, they are typically present at from about 0.1% to 10%, preferably from 0.1% to 8%, more preferably from 0.1% to about 5% of the cleansing compositions.
  • the stabilizer is insoluble in water under ambient to near ambient conditions.
  • the stabilizer employed in the cleansing compositions herein can comprise a polymeric thickener.
  • polymeric thickeners as the stabilizer in the cleansing compositions herein they are typically included in an amount ranging from about 0.01% to about 5%, preferably from about 0.3% to about 3%, by weight of the composition.
  • the polymeric thickener is preferably an anionic, nonionic, cationic or hydrophobically modifier polymer selected from the group consisting of cationic polysaccharides of the cationic guar gum class with molecular weights of 1,000 to 3,000,000, anionic, cationic, and nonionic homopolymers derived from acrylic and/or methacrylic acid, anionic, cationic, and nonionic cellulose resins, cationic copolymers of dimethyldialkylammonium chloride, and acrylic acid, cationic homopolymers of dimethylalkylammonium chloride, cationic polyalklene and ethoxypolyalkylene imines, polyethylene glycol of molecular weight from 100,000 to 4,000,000, and mixtures thereof.
  • the polymer is selected from the group consisting of sodium polyacrylate, hydroxy ethyl cellulose, cetyl hydroxy ethyl Cellulose, and Polyquaternium 10.
  • the stabilizer employed in the cleansing compositions herein can comprise C10-C22 ethylene glycol fatty acid esters.
  • C10-C22 ethylene glycol fatty acid esters can also desirably be employed in combination with the polymeric thickeners hereinbefore described.
  • the ester is preferably a diester, more preferably a C14-C18 diester, most preferably ethylene glycol distearate.
  • C10-C22 ethylene glycol fatty acid esters are utilized as the stabilizer in the personal cleansing compositions herein, they are typically present at from about 3% to about 10%, preferably from about 5% to about 8%, more preferably from about 6% to about 8% of the personal cleansing compositions.
  • Another class of stabilizer which can be employed in the cleansing compositions of the present invention comprises dispersed amorphous silica selected from the group consisting of fumed silica and precipitated silica and mixtures thereof.
  • dispersed amorphous silica refers to small, finely divided non-crystalline silica having a mean agglomerate particle size of less than about 100 microns.
  • Fumed silica which is also known as arced silica, is produced by the vapor phase hydrolysis of silicon tetrachloride in a hydrogen oxygen flame. It is believed that the combustion process creates silicone dioxide molecules which condense to form particles. The particles collide, attach and sinter together. The result of this process is a three dimensional branched chain aggregate. Once the aggregate cools below the fusion point of silica, which is about 1710° C., further collisions result in mechanical entanglement of the chains to form agglomerates. Precipitated silicas and silica gels are generally made in aqueous solution.
  • the fumed silica preferably has a mean agglomerate particle size ranging from about 0.1 microns to about 100 microns, preferably from about 1 micron to about 50 microns, and more preferably from about 10 microns to about 30 microns.
  • the agglomerates are composed of aggregates which have a mean particle size ranging from about 0.01 microns to about 15 microns, preferably from about 0.05 microns to about 10 microns, more preferably from about 0.1 microns to about 5 microns and most preferably from about 0.2 microns to about 0.3 microns.
  • the silica preferably has a surface area greater than 50 sq. m/gram, more preferably greater than about 130 sq. m./gram, most preferably greater than about 180 sq. m./gram.
  • amorphous silicas are typically included in the cleansing compositions at levels ranging from about 0.1% to about 10%, preferably from about 0.25% to about 8%, more preferably from about 0.5% to about 5%.
  • a fourth class of stabilizer which can be employed in the cleansing compositions of the present invention comprises dispersed smectite clay selected from the group consisting of bentonite and hectorite and mixtures thereof.
  • Bentonite is a colloidal aluminum clay sulfate.
  • Hectorite is a clay containing sodium, magnesium, lithium, silicon, oxygen, hydrogen and flourine. See Merck Index, eleventh Edition, 1989, entry 4538, p. 729, which is herein incorporated by reference.
  • smectite clay When smectite clay is employed as the stabilizer in the cleansing compositions of the present invention, it is typically included in amounts ranging from about 0.1% to about 10%, preferably from about 0.25% to about 8%, more preferably from about 0.5% to about 5%.
  • Palmitic acid and lauric acid are especially preferred for use herein.
  • compositions of the present invention can comprise a wide range of optional ingredients.
  • Nonlimiting examples of functional classes of ingredients are described at page 537 of this reference.
  • Examples of these functional classes include: abrasives, anti-acne agents, anticaking agents, antioxidants, binders, biological additives, bulking agents, chelating agents, chemical additives, colorants, cosmetic astringents, cosmetic biocides, denaturants, drug astringents, emulsifiers, external analgesics, film formers, fragrance components, humectants, opacifying agents, plasticizers, preservatives, propellants, reducing agents, skin bleaching agents, skin-conditioning agents (emollient, humectants, miscellaneous, and occlusive), skin protectants, solvents, foam boosters, hydrotropes, solubilizing agents, suspending agents (nonsurfactant), sunscreen agents, ultraviolet light absorbers, and viscosity increasing agents (aqueous and nonaqueous).
  • Examples of other functional classes of materials useful herein that are well known to one of ordinary skill in the art include solubilizing agents, sequestrants,
  • compositions of the present invention can also be, optionally, incorporated into a insoluble substrate for application to the skin such as in the form of a treated wipe.
  • a insoluble substrate for application to the skin
  • Suitable water insoluble substrate materials and methods of manufacture are described in Riedel, “Nonwoven Bonding Methods and Materials,” Nonwoven World (1987); The Encyclopedia Americana, vol. 11, pp. 147-153, vol. 21, pp. 376-383, and vol. 26, pp. 566-581 (1984); U.S. Pat. No. 3,485,786 to Evans, issued Dec. 23, 1969;; U.S. Pat. No. 2,862,251, to Kalwarres; U.S. Pat. No. 3,025,585, Kalwarres; U.S. Pat. No.
  • Nonwoven substrates made from synthetic materials useful in the present invention can also be obtained from a wide variety of commercial sources.
  • suitable nonwoven layer materials useful herein include PGI Miratec Herringbone, a patterned hydroentangled material containing about 30% rayon and 70% polyester, and having a basis weight of about 56 grams per square yard (gsy), available from PGI/Chicopee, Dayton N.J.; PGI Miratec Starburst, a patterned hydroentangled material containing about 30% rayon and 70% polyester, and having a basis weight of about 56 grams per square yard (gsy), available from PGI/Chicopee, Dayton N.J.; Novonet R 149-616, a thermo-bonded grid patterned material containing about 100% polypropylene, and having a basis weight of about 50 gsy, available from Veratec, Inc., Walpole, Mass.
  • Novonet R 149-801 a thermo-bonded grid patterned material containing about 69% rayon, about 25% polypropylene, and about 6% cotton, and having a basis weight of about 75 gsy, available from Veratec, Inc. Walpole, Mass.
  • Novonet R 149-191 a thermo-bonded grid patterned material containing about 69% rayon, about 25% polypropylene, and about 6% cotton, and having a basis weight of about 100 gsy, available from Veratec, Inc. Walpole, Mass.
  • HEF Nubtex R 149-801 a nubbed, apertured hydroentangled material, containing about 100% polyester, and having a basis weight of about 70 gsy, available from Veratec, Inc.
  • the water insoluble substrate can be a polymeric mesh sponge as described in U.S. Pat. No. 5,650,384, incorporated by reference herein in its entirety.
  • the polymeric sponge comprises a plurality of plies of an extruded tubular netting mesh prepared from a strong flexible polymer, such as addition polymers of olefin monomers and polyamides of polycarboxylic acids.
  • these polymeric sponges are designed to be used in conjunction with a liquid cleanser, these types of sponges can be used as the water insoluble substrate in the present invention.
  • the skin cleansing compositions of the present invention are useful for disinfecting and cleansing the skin.
  • the skin disinfection and cleansing process involves topically applying to the skin a safe and effective amount of a composition of the present invention.
  • the present invention can be used when cleansing processes requiring soap and water are unavailable or inconvenient.
  • the amount of the composition applied, the frequency of application and the period of use will vary widely depending upon the level of disinfection and cleansing desired, e.g., the degree of microbial contamination and/or skin soiling.
  • Typical amounts of cleansing composition used preferably range from about 0.1 mg/cm 2 to about 20 mg/cm 2 , more preferably from about 0.5 mg/cm 2 to about 10 mg/cm 2 , and most preferably about 1 mg/ cm 2 to about 5 mg/cm 2 of skin area to be cleansed.
  • the cleansing compositions of the present invention are used to cleanse and disinfect human and/or animal skin.
  • the present invention also encompasses the method of applying an effective amount of the cleansing compositions of the present invention onto non-skin surfaces, such as household surfaces, e.g., countertops, kitchen surfaces, food preparing surfaces (cutting boards, dishes, pots and pans, and the like); major household appliances, e.g., refrigerators, freezers, washing machines, automatic dryers, ovens, microwave ovens, dishwashers; cabinets; walls; floors; bathroom surfaces, shower curtains; garbage cans and/or recycling bins, and the like.
  • non-skin surfaces such as household surfaces, e.g., countertops, kitchen surfaces, food preparing surfaces (cutting boards, dishes, pots and pans, and the like); major household appliances, e.g., refrigerators, freezers, washing machines, automatic dryers, ovens, microwave ovens, dishwashers; cabinets; walls; floors; bathroom surfaces, shower curtains; garbage cans and/or recycling bins, and the like.
  • the present invention also relates to an article of manufacture comprising a dispensing container containing the cleansing composition.
  • Said dispensing container can be constructed of any of the conventional material employed in fabricating containers, including, but not limited to: polyethylene; polypropylene; polyacetal; polycarbonate; polyethyleneterephthalate; polyvinyl chloride; polystyrene; blends of polyethylene, vinyl acetate, and rubber elastomer. Other materials can include stainless steel and glass.
  • a preferred container is made of clear material, e.g., polyethylene terephthalate.
  • the dispensing container is a spray dispenser.
  • Said spray dispenser is any of the manually activated means for producing a spray of liquid droplets as is known in the art.
  • a preferred spray container is made of clear material, e.g., polyethylene terephthalate.
  • Any method suitable for the application of aqueous or aqueous/alcoholic impregnates can be used to impregnate the fibrous webs herein with the cleansing compositions described herein. More specialized techniques, such as Meyer Rod, floating knife or doctor blade, which are typically used to impregnate liquids into absorbent sheets may also be used.
  • the emulsion should preferably comprise from about 100% to about 400%, preferably from about 100% to about 300% by weight of the absorbent sheet.
  • the sheets may be folded into stacks and packaged in any of the moisture and vapor impermeable packages known in the art.
  • anti-microbial cleansing compositions of the present invention are made via art recognized techniques for the various forms compositions.
  • the cleansing compositions and wipe of the present invention are useful for personal cleansing, reducing germs on skin, and providing residual effectiveness versus microorganisms such as fungus and bacteria as well as viruses.
  • the wipe is used to apply the cleansing compositions to the area to be cleansed.
  • the wipes herein can be used for personal cleansing when the use of cleansing products requiring water cannot be, or are inconvenient.
  • Typical quantities of the present wipes useful for cleansing range from about 1 to about 4 wipes per use, preferably from about 1 to about 2 wipes per use.
  • Typical amounts of cleansing composition used range from about 4 mg/cm 2 to about 6 mg/cm 2 , preferably about 5 mg/cm 2 of skin area to be cleansed.
  • Ingredients are identified by chemical or CTFA name.
  • a patterned hydroentangled non-woven substrate having a basis weight of 56 gms, comprising 70% polyester and 30% rayon approximately 6.5 inches wide by 7.5 inches long with a caliper of about 0.80 mm.
  • the substrate can be pre-coated with dimethicone (Dow Corning 200 Fluid 5cst) using conventional substrate coating techniques.
  • the pyroglutamic acid, sodium chloride and water are added and mixed with stirring until mixture is homogeneous.
  • Sodium benzoate, tetrasodium EDTA and cocamine oxide are then added to the mixture with stirring and mixed until the ingredients are completely dissolved.
  • the DC Antiform H-10 is added to the mixture with stirring.
  • the perfume and ethanol are mixed to form a premix.
  • the premix is then added to the cocamine oxide mixture to form the aqueous lotion.
  • the aqueous lotion is pH adjusted to about 3.0 using NaOH or HCl.
  • the aqueous lotion is applied to the skin in an appropriate amount to disinfect and cleanse the skin.
  • the aqueous lotion can be applied onto the substrate of Example 1 at a lotion to wipe weight ratio of about 2:1 using conventional substrate coating techniques for application to the skin as an antimicrobial and cleansing wipe.
  • the pyroglutamic acid, sodium chloride and water are added and mixed with stirring until mixture is homogeneous.
  • Sodium benzoate, tetrasodium EDTA and cocamine oxide are then added to the mixture with stirring and mixed until the ingredients are completely dissolved.
  • the DC Antiform H-10 is added to the mixture with stirring.
  • the perfume and ethanol are mixed to form a premix.
  • the premix is then added to the cocamine oxide mixture to form the aqueous lotion.
  • the Tospearl is added into the aqueous lotion with stirring until homogeneous.
  • the aqueous lotion is pH adjusted to about 3.0 using NaOH or HCl.
  • the aqueous lotion is applied to the skin in an appropriate amount to disinfect and cleanse the skin.
  • the aqueous lotion can be applied onto the substrate of Example 1 at a lotion to wipe weight ratio of about 2:1 using conventional substrate coating techniques for application to the skin as an antimicrobial and cleansing wipe.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

Disclosed are cleansing compositions having a pH of from about 2.0 to about 5.5, comprising an amphoteric surfactant in combination with 2-pyrrolidone-5 carboxylic acid as a proton donating agent. Also disclosed are corresponding articles of manufacture and methods of cleansing the skin using the described compositions. The compositions are mild to the skin and provide immediate and residual antimicrobial benefits to the skin.

Description

    CROSS REFERENCES TO RELATED APPLICATIONS
  • This application claims the benefit of U.S. Provisional Application Nos. 60/177,091 and 60/177,092, filed on Jan. 20, and 60/191,939, filed on Mar. 24, 2000.[0001]
  • TECHNICAL FIELD
  • The present invention relates to cleansing compositions comprising an amphoteric surfactant in combination with 2-pyrrolidone-5 carboxylic acid, wherein the composition provides immediate and residual antimicrobial activity on the applied areas of the skin. The present invention also relates to corresponding articles of manufacture and methods of cleansing the skin using the cleansing compositions of the present invention. [0002]
  • BACKGROUND OF THE INVENTION
  • Human health is impacted by a variety of microbial organisms. Inoculation of humans or other mammals by these microorganisms often results in various sicknesses and ailments. Public awareness of such contaminations has been heightened due to the increased number of food poisonings, streptococcal infections, etc. which have been occurring in the recent past. Consequently, there has been a thrust by the medical community to persuade the general public to wash any areas which generally come in contact with infected surfaces like body parts (e.g. hand washing), foods (e.g., uncooked meat, vegetables, fruits, etc.), cooking utensils, cooking surfaces (e.g., counter tops, sinks, etc.). It has been found that such methods are important in attempts to remove pathogenic microorganisms from human skin as well as other surfaces. [0003]
  • The types of microorganisms which can be found on mammalian skin include viruses, bacteria, and fungi. In general, virologists agree that rhinoviruses, influenza viruses, and adenoviruses are most likely the most relevant viruses which cause respiratory diseases. It is believed that rhinoviruses, in particular, are responsible for acting as the primary cause for the common cold. Rhinoviruses are members of the picornavirus family. As such they are referred to as “naked viruses” since they lack an outer envelope. Such picornaviruses are known to be difficult to inactivate by commonly used means like quaternary ammonium compounds. [0004]
  • Rhinovirus infections are spread from person to person by means of virus-contaminated respiratory secretions. Evidence suggests that the primary mode of transmission is via direct contact, as opposed to inhalation of airborne viral particles. It has been demonstrated that ill persons have a propensity to contaminate their hands and environmental objects. Rhinovirus has been recovered from 40 to 90% of hands of persons experiencing colds and from 6 to 15% of diverse objects. Rhinovirus exhibits good survival on many environmental surfaces for hours after contamination, and infection is readily transmitted by finger-to-finger contact and by finger to contaminated environmental surface if the newly contaminated finger is then used to rub an eye or touch the nasal mucosa. [0005]
  • Since a substantial proportion of rhinovirus colds are transmitted by direct contact from virus-contaminated hands or objects, it is possible to lower the risk of acquiring infection by inactivating virus on hands or surfaces. A common household phenol/alcohol disinfectant has been shown to be effective in disinfecting contaminated environmental surfaces but lacks residual virucidal effects. Hand washing is highly effective at disinfecting contaminated fingers, but again, suffers from a lack of residual antiviral activity. These shortcomings provide strong opportunities for improved virucidal technologies with residual activity against rhinoviruses. [0006]
  • As to bacterial microorganisms, most are generally categorized as either gram positive or gram negative. Gram positive bacteria are often established as permanent microcolonies on the surface and outermost layers of mammalian skin. Such bacteria play an important role in preventing the colonization of other more harmful bacteria and fungi. Transient bacteria, however, are not part of the normal resident flora of the skin but can be deposited when airborne contaminated material lands on the skin or when contaminated material is brought into physical contact with the skin. Transient bacteria can include gram positive and Gram negative bacteria, including gram positive pathogens such as [0007] Staphylococcus aureus, Streptococcus pyogenes and Clostridium botulinum, and gram negative pathogens such as Salmonella, Escherichia coli, Klebsiella, Haemophilus, Pseudomonas aeruginosa, Proteus and Shigella dysenteriae. Gram negative bacteria are generally distinguished from Gram positive by an additional protective cell membrane which generally results in the gram negative bacteria being less susceptible to topical antibacterial actives.
  • There are many types of bacterial pathogens that can infect humans and other mammals. As such, a number of products have been developed over the years which are effective for providing immediate antimicrobial efficacy, that is, anti-viral and/or antibacterial efficacy. These products range from personal cleansing products such as hand soaps to household cleaning products such as disinfectant sprays and cleansers. Most of these products, however, fail to provide residual activity or efficacy against pathogenic viruses and bacteria to the areas they are used to treat. [0008]
  • There is therefore a need for compositions and products which provide immediate and residual anti-viral and/or antibacterial efficacy, as well as improved residual antifungal efficacy. There is also a need to provide improved immediate anti-viral (e.g., anti-rhinoviral) activity, and antibacterial activity in water based systems (i.e., non-alcohol). There is an additional need to provide compositions and products which exhibit improved antifungal efficacy. [0009]
  • It has now been found that the compositions of the present invention can be formulated to provide improved mildness to the skin and improved antibacterial, antiviral, and/or antifungal activity, wherein the compositions contain 2-pyrrolidone-5 carboxylic acid in combination with an amphoteric surfactant, which combination is deposited on the skin during application. It has been found that the 2-pyrrolidone-5 carboxylic acid component functions as a proton donating agent when used in combination with the amphoteric surfactant, wherein the proton donating effect of this particular acid provides immediate and residual antiviral, antibacterial, and/or antifungal activity on the applied areas of the skin. [0010]
  • SUMMARY OF THE INVENTION
  • The present invention relates to cleansing compositions, comprising from about 0.05% to about 10%, by weight of the composition, of an amphoteric surfactant; from about 0.1% to about 10%, by weight of the composition, of 2-pyrrolidone-5 carboxylic acid; and from about 3% to about 99.89%, by weight of the composition, of an aqueous component. The cleansing compositions of the present invention have a pH in the range of from about 2.0 to about 5.5. [0011]
  • The present invention also relates to articles of manufacture and methods of cleansing the skin comprising the disclosed compositions. [0012]
  • DETAILED DESCRIPTION OF THE INVENTION
  • The cleansing compositions of the present invention are highly effective in providing an improved germ reduction on the skin, are mild to the skin and can be used without additional available water. [0013]
  • The term “safe and effective amount” as used herein means an amount of a compound or composition sufficient to significantly induce a positive benefit, preferably an antimicrobial benefit, but low enough to avoid serious side effects, i.e., to provide a reasonable benefit to risk ratio, within the scope of sound judgment of the skilled artisan. [0014]
  • All percentages and ratios used herein, unless otherwise indicated, are by weight and all measurements made are at 25° C., unless otherwise specified. The invention hereof can comprise, consist of, or consist essentially of, the essential as well as optional ingredients and components described therein. [0015]
  • The cleansing composition of the present invention comprise the following essential components. These components are selected so that the efficacy and optional mildness requirements hereinafter defined for the compositions herein are met. The selection of each component is necessarily dependent on the selection of each of the other components. If a harsh surfactant is utilized, then a mildness agent may have to be utilized. Guidelines for the selection of the individual components are provided herein. [0016]
  • Amphoteric Surfactant
  • The cleansing compositions of the present invention comprise from about 0.01% to about 40%, preferably from about 0.01 % to about 20%, more preferably from about 0.05% to about 10%, and most preferably from about 0.05% to about 10%, by weight of the cleansing composition, of an amphoteric surfactant. [0017]
  • Amphoteric surfactants useful in the present invention are those having the following general formulae (I) (II), (III), (IV), (V) or mixtures thereof: [0018]
    Figure US20020172656A1-20021121-C00001
  • wherein R[0019] 1 is an alkyl alkenyl, aryl, or hydroxyalkyl radical of from about 8 to about 22 carbon atoms, optionally interrupted with up to about 10 ethylene oxide moieties and/or 1 glyceryl moiety, R2 and R3 are individually selected from alkyl and monohydroxyalkyl groups containing from about 1 to about 3 carbon atoms, R4 is alkylene, or hydroxyalkylene of from about 1 to about 4 carbon atoms, Z1 is a radical selected from carboxylate, sulfonate, sulfate, phosphate, or phosphonate, x is 0 or 1, n is from about 1 to about 6, and m is 0 or 1. Preferably, R1 is an alkyl, alkenyl, or hydroxyalkyl radical of from 11 to 17 carbon atoms, R2 and R3 are individually selected from alkyl groups containing of from 1 to 3 carbon atoms, R4 is alkylene or hydroxyalkylene of from 1 to 2 carbon atoms, Z1 is a radical selected from carboxylate, sulfonate, x is 0 or 1, n is 1 to 3, and m is 0 or 1.
    Figure US20020172656A1-20021121-C00002
  • wherein R[0020] 5 is C8-C22 alkyl, alkenyl, aryl, or hydroxyalkyl, preferably C8-C22, R6 is hydrogen or CH2CO2M1, R7 is CH2CH2OH or CH2CH2OCH2CH2COOM1, R8 is hydrogen, CH2CH2OH, or CH2CH2OCH2CH2COOM1, Z2 is CO2M1 or CH2CO2M1, y is 2 or 3, preferably 2, M1 is hydrogen or a cation, such as alkali metal, alkaline earth metal, ammonium, alkanol ammonium, sulfate, sulfonate, phosphate, or phosphonate.
  • R9—NH(CH2)aCOOM2   (III)
  • R9—N[(CH2)aCOOM2]2   (IV)
  • wherein a is a number from 1 to 4, R[0021] 9 is C8-C22 alkyl, alkenyl, aryl, hydroxyalkyl or alkylamidoalkyls, and M2 is hydrogen, alkali metal, alkaline earth metal, ammonium or alkanolammonium.
    Figure US20020172656A1-20021121-C00003
  • wherein R[0022] 10 or R12 is methyl; ethyl, or hydroxyethyl, and R11 is C8-C22 alkyl, alkenyl, or aryl, or CH3(CH2)pCONH(CH2)q wherein p is 8-22 and q is 1-6. Preferably, R10 and R12 are methyl, R11 is C10-18 alkyl, alkenyl, p is 11-17, and q is 1-3.
  • Examples of amphoteric surfactants useful in the cleansing compositions having general formula (I) are amide betaines, amide sulfo betaines, alkyl betaines, alkenyl betaines, sultaines (sulfo betaines), and imidazolinium betaines. Examples of amphoteric surfactants particularly useful are high alkyl betaines, such as coco dimethyl carboxymethyl betaine, cocamnidopropyl betaine under the trade name of TEGO BETAINE, coco betaine, lauryl betaine under the trade name REWOTERIC AM DML-35, lauryl amidopropyl betaine, oleyl betaine, lauryl dimethyl carboxymethyl betaine, lauryl dimethyl alpha-carboxyethyl betaine, cetyl dimethyl carboxymethyl betaine, lauryl bis-(2-hydroxyethyl) carboxymethyl betaine, stearyl bis-(2-hydroxypropyl) carboxymethyl betaine, oleyl dimethyl gamma-carboxypropyl betaine, lauryl bis-(2-hydroxypropyl) alpha-carboxyethyl betaine, cocamnidopropyl hydroxy sultaine (sulfobetaine), lauryl sultaine (lauryl sulfobetaine), and cocamidopropryl hydroxy sultaine under the trade name REWOTERIC AM CAS. [0023]
  • Examples of amphoteric surfactants useful in the cleansing compositions having general formula (II) are marketed under the trade name MIRANOL and are understood to comprise a complex mixture of species, and can exist in protonated and non-protonated species depending upon pH with respect to species that can have a hydrogen at R[0024] 6. The imidazolinium amphoteric surfactant hereof can be derived via an imidazolinium intermediate.
  • Preferred amphoteric surfactants of formula (II) are monocarboxylates and dicarboxylates. Examples of these materials include cocoamphocarboxypropionate, cocoamphocarboxypropionic acid, cocoamphocarboxyglycinate (alternately referred to as cocoamphodiacetate), and cocoamphoacetate. [0025]
  • Specific commercial products providing the imidazolinium derivative component of the present compositions include those sold under the trade names MIRANOL C2M CONC. N.P., MIRANOL C2M CONC. O.P., MIRANOL C2M SF, MIRANOL CM SPECIAL (Miranol, Inc.); ALKATERIC 2CIP (Alkaril Chemicals); cocoamphocarboxy propionate under the trade name NIKKOL AM-101, AMPHOTERGE W-2 (Lonza, Inc.); MONATERIC CDX-38, MONATERIC CSH-32 (Mona Industries); REWOTERIC AM-2C (Rewo Chemical Group); and SCHEROTERIC MS-2 (Scher Chemicals). [0026]
  • Examples of amphoteric surfactants useful in the cleansing compositions having general formulae (III) and (IV) include n-alkylaminopropionates and n-alkyliminodipropionates. Such materials are sold under the trade name DERIPHAT by Henkel and MIRATAINE by Miranol, Inc. Specific examples include N-lauryl-beta-amino propionic acid or salts thereof, and N-lauryl-beta-imino-dipropionic acid or salts thereof. [0027]
  • Examples of amphoteric surfactants useful in the cleansing compositions having general formula (V) are commonly known as amine oxides. Also useful are tertiary phosphine oxides and dialkyl sulfoxides. Mixtures of the above amphoteric surfactants can also be used. [0028]
  • The most preferred amphoteric surfactants are amine oxides. Examples of amine oxides particularly useful in the cleansing compositions are cocamine oxide, lauramine oxide under the trade name AMMONYX LO, and stearamidopropylamine oxide under the trade name VAROX 1770. [0029]
  • 2-Pyrrolidone-5 Carboxylic Acid
  • The cleansing compositions of the present invention comprise 2-pyrrolidone-5 carboxylic acid as a proton donating agent at concentrations ranging from about 0.1% to about 20%, preferably from about 0.1% to about 10%, more preferably from about 0.5% to about 8%, and most preferably from about 1% to about 5%, by weight of the composition. [0030]
  • The term “proton donating agent” as used herein refers to the 2-pyrrolidone-5 carboxylic acid component of the cleansing compositions that is ultimatile applied topically to the skin and that results in undissociated acid on the applied area of the skin after application. This particular proton donating agent remains at least partially undissociated in the neat composition and when the compositions are diluted during washing and rinsing. This particular proton donating agent can be added directly to the cleansing composition in the acid form or can be formed by adding the conjugate base of the desired acid and a sufficient amount of a separate acid strong enough to form the undissociated acid from the base. [0031]
  • Composition pH
  • It is critical to achieving the benefits of the invention that the undissociated acid from the selected proton donating agent (2-pyrrolidone-5 carboxylic acid as deposited or formed in-situ) remain on the skin in the protonated form. Therefore, the pH of the cleansing compositions of the present invention must be adjusted to a sufficiently low level in order to either form or deposit substantial undissociated acid on the skin. The pH of the compositions should be adjusted and preferably buffered to range from about 2.0 to about 5.5, preferably from about 2.5 to about 5.0 and more preferably from about 2.5 to about 4.5. [0032]
  • It has been found that 2-pyrrolidone-5 carboxylic acid as the selected proton donating agent in the compositions of the present invention is milder to the skin and causes less stinging than many other acids that are likewise suitable for topical application to the skin. [0033]
  • Aqueous Component
  • The cleansing compositions described herein additionally comprise an aqueous component. For purposes of this invention the term “aqueous component” refers to any material consisting essentially of, or predominantly of water, water soluble alcohol(s) such as ethanol, propanol or isopropanol, and mixtures thereof. [0034]
  • The aqueous component can optionally contain one or more water-soluble emollients including, but not limited to, lower molecular weight aliphatic diols such as propylene glycol and butylene glycol; polyols such as glycerine and sorbitol; and polyoxyethylene polymers such as polyethylene glycol 200. The specific type and amount of water soluble emollient(s) employed will vary depending on the desired aesthetic characteristics of the composition, and is readily determined by one skilled in the art. [0035]
  • The aqueous component is preferably water which is deionized, distilled or purified. Preferred cleansing compositions comprise from about 3% to about 99.89%, preferably from about 5% to about 98%, more preferably from about 10% to about 97.5%, and most preferably from about 38% to about 95.99% , by weight of the aqueous component. [0036]
  • Preferred Optional Ingredients Antimicrobial Active
  • The cleansing compositions of the present invention may further comprise an antibacterial active at concentrations ranging from about 0.001% to about 5%, preferably from about 0.05% to about 1%, more preferably from about 0.05% to about 0.5%, even more preferably from about 0.1% to about 0.25%, by weight of the cleansing composition. The exact amount of antibacterial active to be used in the compositions will depend upon factors such as the particular antimicrobial active utilized since actives vary in potency. [0037]
  • Given below are examples of non-cationic antimicrobial agents which are useful in the compositions of the present invention: [0038]
  • Pyrithiones, especially the zinc complex (ZPT) [0039]
  • Benzalkonium Chloride [0040]
  • Di(C[0041] 6-C14)alkyl di short chain (C1-4 alkyl and/or hydroxyalkyl)
  • N—(3 -chloroallyl) hexaminium chlorides [0042]
  • Benzethonium chloride [0043]
  • Methylbenzethonium [0044]
  • Octopirox®[0045]
  • Dimethyldimethylol Hydantoin (Glydant®) [0046]
  • Methylchloroisothiazolinone/methylisothiazolinone (Kathon CG®) [0047]
  • Sodium Sulfite [0048]
  • Sodium Bisulfite [0049]
  • Imidazolidinyl Urea (Germall 115®) [0050]
  • Diazolidinyl Urea (Germaill II®) [0051]
  • Benzyl Alcohol [0052]
  • 2-Bromo-2-nitropropane- 1,3-diol (Bronopol®) [0053]
  • Formalin (formaldehyde) [0054]
  • Iodopropenyl Butylcarbamate (Polyphase P100®) [0055]
  • Chloroacetamiide [0056]
  • Methanamine [0057]
  • Methyldibromonitrile Glutaronitrile (1,2-Dibromo-2,4-dicyanobutane or Tektamer®) [0058]
  • Glutaraldehyde [0059]
  • 5-bromo-5-nitro-1,3-dioxane (Bronidox®) [0060]
  • Phenethyl Alcohol [0061]
  • o-Phenylphenol/sodium o-phenylphenol [0062]
  • Sodium Hydroxymethylglycinate (Suttocide A®) [0063]
  • Polymethoxy Bicyclic Oxazolidine (Nuosept C®) [0064]
  • Dimethoxane [0065]
  • Thimersal [0066]
  • Dichlorobenzyl Alcohol [0067]
  • Captan [0068]
  • Chlorphenenesin [0069]
  • Dichlorophene [0070]
  • Chlorbutanol [0071]
  • Glyceryl Laurate [0072]
  • Halogenated Diphenyl Ethers [0073]
  • 2,4,4′-trichloro-2′-hydroxy-diphenyl ether (Triclosan® or TCS) [0074]
  • 2,2′-dihydroxy-5,5′-dibromo-diphenyl ether [0075]
  • Phenolic Compounds [0076]
  • Phenol [0077]
  • 2-Methyl Phenol [0078]
  • 3-Methyl Phenol [0079]
  • 4-Methyl Phenol [0080]
  • 4-Ethyl Phenol [0081]
  • 2,4-Dimethyl Phenol [0082]
  • 2,5-Dimethyl Phenol [0083]
  • 3,4-Dimethyl Phenol [0084]
  • 2,6-Dimethyl Phenol [0085]
  • 4-n-Propyl Phenol [0086]
  • 4-n-Butyl Phenol [0087]
  • 4-n-Amyl Phenol [0088]
  • 4-tert-Amyl Phenol [0089]
  • 4-n-Hexyl Phenol [0090]
  • 4-n-Heptyl Phenol [0091]
  • Mono- and Poly-Alkyl and Aromatic Halophenols [0092]
  • p-Chlorophenol [0093]
  • Methyl p-Chlorophenol [0094]
  • Ethyl p-Chlorophenol [0095]
  • n-Propyl p-Chlorophenol [0096]
  • n-Butyl p-Chlorophenol [0097]
  • n-Amyl p-Chlorophenol [0098]
  • sec-Amyl p-Chlorophenol [0099]
  • n-Hexyl p-Chlorophenol [0100]
  • Cyclohexyl p-Chlorophenol [0101]
  • n-Heptyl p-Chlorophenol [0102]
  • n-Octyl p-Chlorophenol [0103]
  • o-Chlorophenol [0104]
  • Methyl o-Chlorophenol [0105]
  • Ethyl o-Chlorophenol [0106]
  • n-Propyl o-Chlorophenol [0107]
  • n-Butyl o-Chlorophenol [0108]
  • n-Amyl o-Chlorophenol [0109]
  • tert-Amyl o-Chlorophenol [0110]
  • n-Hexyl o-Chlorophenol [0111]
  • n-Heptyl o-Chlorophenol [0112]
  • o-Benzyl p-Chlorophenol [0113]
  • o-Benxyl-m-methyl p-Chlorophenol [0114]
  • o-Benzyl-m, m-dimethyl p-Chlorophenol [0115]
  • o-Phenylethyl p-Chlorophenol [0116]
  • o-Phenylethyl-m-methyl p-Chlorophenol [0117]
  • 3-Methyl p-Chlorophenol [0118]
  • 3,5-Dimethyl p-Chlorophenol [0119]
  • 6-Ethyl-3-methyl p-Chlorophenol [0120]
  • 6-n-Propyl-3-methyl p-Chlorophenol [0121]
  • 6-iso-Propyl-3-methyl p-Chlorophenol [0122]
  • 2-Ethyl-3,5-dimethyl p-Chlorophenol [0123]
  • 6-sec-Butyl-3-methyl p-Chlorophenol [0124]
  • 2-iso-Propyl-3,5-dimethyl p-Chlorophenol [0125]
  • 6-Diethylmethyl-3-methyl p-Chlorophenol [0126]
  • 6-iso-Propyl-2-ethyl-3-methyl p-Chlorophenol [0127]
  • 2-sec-Amyl-3,5-dimethyl p-Chlorophenol [0128]
  • 2-Diethylmethyl-3,5-dimethyl p-Chlorophenol [0129]
  • 6-sec-Octyl-3-methyl p-Chlorophenol [0130]
  • p-Chloro-m-cresol [0131]
  • p-Bromophenol [0132]
  • Methyl p-Bromophenol [0133]
  • Ethyl p-Bromophenol [0134]
  • n-Propyl p-Bromophenol [0135]
  • n-Butyl p-Bromophenol [0136]
  • n-Amyl p-Bromophenol [0137]
  • sec-Amyl p-Bromophenol [0138]
  • n-Hexyl p-Bromophenol [0139]
  • Cyclohexyl p-Bromophenol [0140]
  • o-Bromophenol [0141]
  • tert-Amyl o-Bromophenol [0142]
  • n-Hexyl o-Bromophenol [0143]
  • n-Propyl-m,m-Dimethyl o-Bromophenol [0144]
  • 2-Phenyl Phenol [0145]
  • 4-Chloro-2-methyl phenol [0146]
  • 4-Chloro-3-methyl phenol [0147]
  • 4-Chloro-3,5-dimethyl phenol [0148]
  • 2,4-Dichloro-3,5-dimethylphenol [0149]
  • 3,4,5,6-Terabromo-2-methylphenol [0150]
  • 5-Methyl-2-pentylphenol [0151]
  • 4-Isopropyl-3-methylphenol [0152]
  • Para-chloro-meta-xylenol (PCMX) [0153]
  • Chlorothymol [0154]
  • Phenoxyethanol [0155]
  • Phenoxyisopropanol [0156]
  • 5-Chloro-2-hydroxydiphenylmethane [0157]
  • Resorcinol and its Derivatives [0158]
  • Resorcinol [0159]
  • Methyl Resorcinol [0160]
  • Ethyl Resorcinol [0161]
  • n-Propyl Resorcinol [0162]
  • n-Butyl Resorcinol [0163]
  • n-Amyl Resorcinol [0164]
  • n-Hexyl Resorcinol [0165]
  • n-Heptyl Resorcinol [0166]
  • n-Octyl Resorcinol [0167]
  • n-Nonyl Resorcinol [0168]
  • Phenyl Resorcinol [0169]
  • Benzyl Resorcinol [0170]
  • Phenylethyl Resorcinol [0171]
  • Phenyipropyl Resorcinol [0172]
  • p-Chlorobenzyl Resorcinol [0173]
  • 5-Chloro 2,4-Dihydroxydiphenyl Methane [0174]
  • 4′-Chloro 2,4-Dihydroxydiphenyl Methane [0175]
  • 5-Bromo 2,4-Dihydroxydiphenyl Methane [0176]
  • 4′-Bromo 2,4-Dihydroxydiphenyl Methane [0177]
  • Bisphenolic Compounds [0178]
  • 2,2′-Methylene bis (4-chlorophenol) [0179]
  • 2,2′-Methylene bis (3,4,6-trichlorophenol) [0180]
  • 2,2′-Methylene bis (4-chloro-6-bromophenol) [0181]
  • bis (2-hydroxy-3,5-dichlorophenyl) sulphide [0182]
  • bis (2-hydroxy-5-chlorobenzyl)sulphide [0183]
  • Benzoic Esters (Parabens) [0184]
  • Methylparaben [0185]
  • Propylparaben [0186]
  • Butylparaben [0187]
  • Ethylparaben [0188]
  • Isopropylparaben [0189]
  • Isobutylparaben [0190]
  • Benzylparaben [0191]
  • Sodium Methylparaben [0192]
  • Sodium Propylparaben [0193]
  • Halogenated Carbanilides [0194]
  • 3,4,4′-Trichlorocarbanilides (Triclocarban®or TCC) [0195]
  • 3-Trifluoromethyl-4,4′-dichlorocarbanilide [0196]
  • 3,3′,4-Trichlorocarbanilide [0197]
  • A more detailed description of suitable antimicrobial agents can be found in U.S. Pat. No. 4,163,800; U.S. Pat. No. 3,152,181; U.S. Pat. No. 5,780,064; and [0198] Remington's pharmaceutical Sciences, 17th ed. (Alfonso R. Gennaro ed., 1985) pp. 1158-1169, which descriptions are incorporated herein by reference.
  • Another class of antibacterial agents that are useful in the compositions of the present invention, are the so-called “natural” antibacterial actives, referred to as natural essential oils. These actives derive their names from their natural occurrence in plants. Typical natural essential oil antibacterial actives include oils of anise, lemon, orange, rosemary, wintergreen, thyme, lavender, cloves, hops, tea tree, citronella, wheat, barley, lemongrass, cedar leaf, cedarwood, cinnamon, fleagrass, geranium, sandalwood, violet, cranberry, eucalyptus, vervain, peppermint, gum benzoin, basil, fennel, fir, balsam, menthol, ocmea origanum, [0199] Hydastis carradensis, Berberidaceae daceae, Ratanhiae and Curcuma longa. Also included in this class of natural essential oils are the key chemical components of the plant oils which have been found to provide the antimicrobial benefit. These chemicals include, but are not limited to anethol, catechole, camphene, carvacol, eugenol, eucalyptol, ferulic acid, farnesol, hinokitiol, tropolone, limonene, menthol, methyl salicylate, thymol, terpineol, verbenone, berberine, ratanhiae extract, caryophellene oxide, citronellic acid, curcumin, nerolidol and geraniol.
  • Other optional antimicrobial actives include antibacterial metal salts. This class generally includes salts of metals in groups 3b-7b, 8 and 3a-5a, and specifically are the salts of aluminum, zirconium, zinc, silver, gold, copper, lanthanum, tin, mercury, bismuth, selenium, strontium, scandium, yttrium, cerium, praseodymiun, neodymium, promethum, samarium, europium, gadolinium, terbium, dysprosium, holmium, erbium, thulium, ytterbium, lutetium and mixtures thereof. [0200]
  • Preferred optional antimicrobial agents for use herein are benzalkonium chloride, benzethonium chloride, triclosan, triclocarban, octopirox, Para-chloro-meta-xylenol (PCMX), zinc pyrithione (ZPT), natural essential oils and their key ingredients, and mixtures thereof. The most preferred antimicrobial active for optional use in the compositions of the present invention is Benzalkonium Chloride. [0201]
  • Mildness Enhancers
  • In order to achieve the mildness benefit from the compositions of the present invention, optional ingredients can be added to enhance the mildness to the skin. These optional ingredients include cationic and nonionic polymers, co-surfactants, moisturizers and mixtures thereof. Polymers useful herein include polyethylene glycols, polypropylene glycols, hydrolyzed silk proteins, hydrolyzed milk proteins, hydrolyzed keratin proteins, guar hydroxypropyltrimonium chloride, polyquats, silicone polymers and mixtures thereof. When used, the mildness enhancing polymers comprise from about 0.1% to about 1%, preferably from about 0.2% to about 1.0%, and more preferably from about 0.2% to about 0.6%, by weight of the cleansing wipe composition, of the composition. Co-surfactants useful herein include nonionic surfactants such as the Genapol® 24 series of ethoxylated alcohols, POE(20) sorbitan monooleate (Tween® 80), polyethylene glycol cocoate and Pluronic® propylene oxide/ethylene oxide block polymers, and amphoteric surfactants such as alkyl betaines, alkyl sultaines, alkyl amphoacetates, alkyl amphodiacetates, alkyl amphopropionates, and alkyl amphodipropionates. When used, the mildness enhancing co-surfacants comprise from about 20% to about 70%, preferably from about 20% to about 50%, by weight of the amphotericsurfactant, of the cleansing composition. [0202]
  • Another group of mildness enhancers are lipid skin moisturizing agents which provide a moisturizing benefit to the user of the cleansing when the lipophilic skin moisturizing agent is deposited to the user's skin. When used in the cleansing compositions herein, lipophilic skin moisturizing agents are used, they are employed at a level of about 0.1% to about 30%, preferably from about 0.2% to about 10%, most preferably from about 0.5% to about 5% by weight of the composition. [0203]
  • In some cases, the lipophilic skin moisturizing agent can desirably be defined in terms of its solubility parameter, as defined by [0204] Vaughan in Cosmetics and Toiletries, Vol. 103, p. 47-69, October 1988. A lipophilic skin moisturizing agent having a Vaughan solubility Parameter (VSP) from 5 to 10, preferably from 5.5 to 9 is suitable for use in the cleansing compositions herein.
  • A wide variety of lipid type materials and mixtures of materials are suitable for use in the cleansing compositions of the present invention. Preferably, the lipophilic skin conditioning agent is selected from the group consisting of hydrocarbon oils and waxes, silicones, fatty acid derivatives, cholesterol, cholesterol derivatives, di- and tri-glycerides, vegetable oils, vegetable oil derivatives, liquid nondigestible oils such as those described in U.S. Pat. No. 3,600,186 to Mattson; Issued Aug. 17, 1971 and U.S. Pat. Nos. 4,005,195 and 4,005,196 to Jandacek et al; both issued Jan. 25, 1977, all of which are herein incorporated by reference, or blends of liquid digestible or nondigestible oils with solid polyol polyesters such as those described in U.S. Pat. No. 4,797,300 to Jandacek; issued Jan. 10, 1989; U.S. Pat. No. 5,306,514, 5,306,516 and 5,306,515 to Letton; all issued Apr. 26, 1994, all of which are herein incorporated by reference, and acetoglyceride esters, alkyl esters, alkenyl esters, lanolin and its derivatives, milk tri-glycerides, wax esters, beeswax derivatives, sterols, phospholipids and mixtures thereof. Fatty acids, fatty acid soaps and water soluble polyols are specifically excluded from our definition of a lipophilic skin moisturizing agent. [0205]
  • Hydrocarbon oils and waxes: Some examples are petrolatum, mineral oil microcrystalline waxes, polyalkenes (e.g. hydrogenated and nonhydrogenated polybutene and polydecene), paraffins, cerasin, ozokerite, polyethylene and perhydrosqualene. Blends of petrolatum and hydrogenated and nonhydrogenated high molecular weight polybutenes wherein the ratio of petrolatum to polybutene ranges from about 90:10 to about 40:60 are also suitable for use as the lipid skin moisturizing agent in the compositions herein. [0206]
  • Silicone Oils: Some examples are dimethicone copolyol, dimethylpolysiloxane, diethyl-polysiloxane, high molecular weight dimethicone, mixed C1-C30 alkyl polysiloxane, phenyl dimethicone, dimethiconol, and mixtures thereof. More preferred are non-volatile silicones selected from dimethicone, dimethiconol, mixed C1-C30 alkyl polysiloxane, and mixtures thereof. Nonlimiting examples of silicones useful herein are described in U.S. Pat. No. 5,011,681, to Ciotti et al., issued Apr. 30, 1991, which is incorporated by reference. [0207]
  • Di- and tri-glycerides: Some examples are castor oil, soy bean oil, derivatized soybean oils such as maleated soy bean oil, safflower oil, cotton seed oil, corn oil, walnut oil, peanut oil, olive oil, cod liver oil, almond oil, avocado oil, palm oil and sesame oil, vegetable oils and vegetable oil derivatives; coconut oil and derivatized coconut oil, cottonseed oil and derivatized cottonseed oil, jojoba oil, cocoa butter, and the like. [0208]
  • Acetoglyceride esters are used and an example is acetylated monoglycerides. [0209]
  • Lanolin and its derivatives are preferred and some examples are lanolin, lanolin oil, lanolin wax, lanolin alcohols, lanolin fatty acids, isopropyl lanolate, acetylated lanolin, acetylated lanolin alcohols, lanolin alcohol linoleate, lanolin alcohol riconoleate. [0210]
  • It is most preferred when at least 75% of the lipophilic skin conditioning agent is comprised of lipids selected from the group consisting: petrolatum, blends of petrolatum and high molecular weight polybutene, mineral oil, liquid nondigestible oils (e.g. liquid cottonseed sucrose octaesters) or blends of liquid digestible or nondigestible oils with solid polyol polyesters (e.g. sucrose octaesters prepared from C22 fatty acids) wherein the ratio of liquid digestible or nondigestible oil to solid polyol polyester ranges from about 96:4 to about 80:20, hydrogenated or nonhydrogenated polybutene, microcrystalline wax, polyalkene, paraffin, cerasin, ozokerite, polyethylene, perhydrosqualene; dimethicones, alkyl siloxane, polymethylsiloxane, methylphenylpolysiloxane and mixtures thereof. When as blend of petrolatum and other lipids is used, the ratio of petrolatum to the other selected lipids (hydrogenated or unhydrogenated polybutene or polydecene or mineral oil) is preferably from about 10:1 to about 1:2, more preferably from about 5:1 to about 1:1. [0211]
  • Degreasing and/or Detackifying Agent
  • Also essential to the compositions of the present invention are degreasing and/or detackifying agents in an effective amount to reduce the greasy feel or stickiness associated with the lipophilic skin moisturizers. The term “degreasing agent,” as used herein, means an agent which prevents, reduces and/or eliminates the greasy or heavy skin feel typically associated with lipophilic materials. The term “detackifying agent,” as used herein, means an agent which prevents, reduces and/or eliminates the sticky or tacky geeling typically associated with ingredients such as humectants. Degreasing or detackifying agents suitable for use in the present invention are selected from the group consisting of select silicones, wax materials soluble in the alcoholic antiseptic and having a melting point greater than about 20° C., powders, fluorochemicals and mixtures thereof. [0212]
  • i) Silicones
  • Useful as degreasing agents in the present invention are volatile and non-volatile silicone oils. The term “nonvolatile” as used herein means that the silicone has a boiling point of at least about 260° C., preferably at least about 275° C., more preferably at least about 300° C. Such materials exhibit very low or no significant vapor pressure at ambient conditions. The term “volatile” as used herein mean that the silicone has a boiling point of from about 99° C. to about 260° C. [0213]
  • Volatile silicones suitable for use in the present invention are disclosed in U.S. Pat. No. 4,781,917, issued to Luebbe et al., Nov. 1, 1988 and U.S. Pat. No. 5,759,529 to LeGrow et al., issued Jun. 2, 1998, both of which are herein incorporated by reference in their entirety. Additionally, a description of various volatile silicones materials is found in Todd et al., “Volatile Silicone Fluids for Cosmetics”, Cosmetics and Toiletries, 91:27-32 (1976). Preferred silicones have surface tensions of less than about 35 dynes, more preferably less than about 30 dynes, most preferably less than about 25 dynes. Particularly preferred volatile silicone oils are selected from the group consisting of cyclic volatile silicones corresponding to the formula: [0214]
    Figure US20020172656A1-20021121-C00004
  • wherein n is from about 3 to about 7; and linear volatile silicones corresponding to the formula: [0215]
  • (CH3)3Si—O—[Si(CH3)2O]·m—Si(CH3)3
  • wherein m is from about 1 to about 7. Linear volatile silicones generally have a viscosity of less than about 5 centistokes at 25.degree. C., whereas the cyclic silicones have viscosities of less than about 10 centistokes at 25.degree. C. Highly preferred examples of volatile silicone oils include cyclomethicones of varying viscosities, e.g., Dow Corning 200, Dow Corning 244, Dow Corning 245, Dow Corning 344, and Dow Corning 345, (commercially available from Dow Corning Corp.); SF-1204 and SF-1202 Silicone Fluids (commercially available from G.E. Silicones), GE 7207 and 7158 (commercially available from General Electric Co.); and SWS-03314 (commercially available from SWS Silicones Corp.). When present in the compositions of the present invention, volatile silicones comprise at least about or greater than about 3% to about 10%, more preferably from about 4% to about 8%, and most preferably from about 6% to about 8% by weight of the present invention. [0216]
  • Also useful as the degreasing agent are nonvolatile silicones such as fluid silicones and gum silicones. The molecular weight and viscosity of the particular selected silicone will determine whether it is a gum or a fluid. The term “silicone fluid,” as used herein, denotes a silicone with viscosities ranging from about 5 to about 600,000 centistokes, most preferably from about 350 to about 100,000 centistokes, at 25° C. The term “silicone gum,” as used herein, denotes silicones with mass molecular weights of from about 200,000 to about 1,000,000 and with viscosities greater than about 600,000 centistokes. The non-volatile silicones of the present invention preferably have a viscosity of at least about 15,000 centipoise, more preferably at least 25,000 centipoise. [0217]
  • Suitable non-volatile silicones include polysiloxanes and other modified silicones. Polysiloxanes and other modified silicones are described in U.S. Pat. Nos. 5,650,144 and 5,840,288, both of which are herein incorporated by reference in their entirety. Examples of suitable polysiloxanes and modified silicones include, but are not limited to, polyalkylsiloxanes, polyarylsiloxanes, polyalkylarylsiloxanes, polyestersiloxanes, polyethersiloxane copolymers, polyfluorosiloxanes, polyaminosiloxanes, and mixtures thereof. Preferred non-volatile polysiloxanes are polydimethylsiloxane having viscosities of from about 5 to about 100,000 centistokes at 25° C. [0218]
  • Silicone fluid and gum mixtures or blends can also be used. Silicone gum and fluid blends are disclosed in U.S. Pat. No. 4,906,459, Cobb et al., issued Mar. 6, 1990; U.S. Pat. No. 4,788,006, Bolich, Jr. et al., issued Nov. 29, 1988; U.S. Pat. No. 4,741,855, Grote et al., issued May 3, 1988; U.S. Pat. No. 4,728,457, Fieler et al., issued Mar. 1, 1988; U.S. Pat. No. 4,704,272, Oh et al., issued Nov. 3, 1987; and U.S. Pat. No. 2,826,551, Geen, issued Mar. 11, 1958; U.S. Pat. No. 5,154,849, Visscher et al., issued Oct. 13, 1992, all of which are herein incorporated by reference in their entirety. [0219]
  • When present in the compositions of the present invention, non-volatile silicones comprise from about 0.01% to about 5%, preferably from about 0.1% to about 2%, more preferably from about 0. 1% to about 1% by weight of the present invention. [0220]
  • Silicone elastomers are also useful as degreasing agents in the present invention. Suitable silicone elastomers are illustrated in U.S. Pat. No. 5,654,362, herein incorporated by reference in its entirety. Examples of suitable elastomers include, but are not limited to, dimethicone crosspolymer, dimethicone/vinyldimethicone corsspolymer, polysilicone-11 and mixtures thereof. Such elastomers can be used alone or with volatile or nonvolatile solvents. Examples of suitable solvents include, but are not limited to, volatile silicones, volatile alcohols, volatile esters, volatile hydrocarbons, and mixtures thereof. The silicone elastomers are crosslinked and preferably have a weight average molecular weight greater than about 100,000. Preferred for use herein are elastomer/solvent blends having an elastomer to solvent ratio of from about 1:100 to about 1:1, more preferably from about 1:30 to about 1:5. Preferably the silicone elastomer blend has a viscosity of from about 50,000 centipoise to about 400,000 centipoise, more preferably from about 100,000 centipoise to about 300,000 centipoise. [0221]
  • Examples of suitable silicone elastomer blends include cyclomethicone and dimethicone crosspolymer blend (Dow Coming®9040 silicone elastomer); cyclomethicone and dimethicone/vinyldimethicone cross polymer blend (SFE 839 elastomer dispersion available from GE); octamethylcyclotetrasiloxane and polysilicone-11 blend (Gransil GCM available from Shin Etsu); and mixtures thereof. Preferred herein is the cyclomethicone and dimethicone/vinyldimethicone cross polymer blend. [0222]
  • When present, the silicone elastomer preferably comprises from about 0.01% to about 5%, preferably from about 0.1% to about 2%. [0223]
  • When present, silicone elastomer or gum blends preferably comprise from about 0.1% to about 10%, preferably from about 1% to about 10%, most preferably from about 4% to about 10% by weight of the composition. [0224]
  • ii.) Wax Materials
  • Wax materials used herein preferably have melting points of at least about or greater than about 20° C., more preferably at least about or greater than about 25° C., and still more preferably at least about or greater than 32° C., and most preferably at least about or greater than about 35° C. The wax materials are preferably soluble in the alcohol antiseptic. The phrase “soluble in the alcohol antiseptic,” as used herein, means the wax materials is soluble in the alcohol antiseptic, at 25° C., at a concentration of 0.1%, preferably 0.2%, more preferably 0.4% by weight, and most preferably soluble at 1.0% by weight. Examples of suitable wax materials include, but are not limited to, dimethicone copolyols having a weight average molecular weight greater than about 1000 such as Biowax®.(supplied by Biosil), polyoxyethylene glycols having weight average molecular weight greater than about 500 such as Carbowax (supplied by Union Carbide), and mixtures thereof. Preferred for use herein is Biowax® 754. [0225]
  • Also preferred for use herein are polyoxyethylene glycols having weight average molecular weight greater than about 500, preferably from about 1000 to about 10,000, more preferably from about 1400 to about 6000. Most preferred is PEG-32 (Carbowax 1450). [0226]
  • When present, the above wax materials preferably comprise from about 0.1% to about 10%, preferably from about 0.1% to about 5%, most preferably from about 0.4% to about 2% by weight of the composition. [0227]
  • iii.) Powders
  • Also useful as degreasing agents are powders. Powder ingredients which may be compounded in the composition of the present invention include inorganic powder such as gums, chalk, Fuller's earth, talc, kaolin, iron oxide, mica, sericite, muscovite, phlogopite, synthetic mica, lepidolite, biotite, lithia mica, vermiculite, magnesium carbonate, calcium carbonate, aluminum silicate, starch, smectite clays, alkyl and/or trialkyl aryl ammonium smectites, chemically modified magnesium aluminum silicate, organically modified montmorillonite clay, hydrated aluminum silicate, fumed silica, aluminum starch octenyl succinate barium silicate, calcium silicate, magnesium silicate, strontium silicate, metal tungstate, magnesium, silica alumina, zeolite, barium sulfate, calcined calcium sulfate (calcined gypsum), calcium phosphate, fluorine apatite, hydroxyapatite, ceramic powder, metallic soap (zinc stearate, magnesium stearate, zinc myristate, calcium palmitate, and aluminum stearate), colloidal silicone dioxide, and boron nitride; organic powder such as polyamide resin powder (nylon powder), cyclodextrin, polyethylene powder, methyl polymethacrylate powder, polystyrene powder, copolymer powder of styrene and acrylic acid, benzoguanamine resin powder, poly(ethylene tetrafluoride) powder, and carboxyvinyl polymer, cellulose powder such as hydroxyethyl cellulose and sodium carboxymethyl cellulose, ethylene glycol monostearate; inorganic white pigments such as titanium dioxide, zinc oxide, and magnesium oxide. Other useful powders are disclosed in U.S. Pat. No. 5,688,831, to El-Nokaly et al., issued Nov. 18, 1997, herein incorporated by reference in its entirety. Preferred for use herein are particulate crosslinked hydrocarbyl-substituted polysiloxane available under the tradename Tospearl from Toshiba Silicone. Mixtures of the above powders may also be used. [0228]
  • Preferably the powders of the present invention have a particle size such that the average chord length of the powder particles range from about 0.01 microns to about 100 microns, preferably from about 0.1 microns to about 50 microns, more preferably from about 1 micron to about 20 microns. [0229]
  • Preferably, the powders of the present invention are spherical or platelet in shape for smooth skin feel. Alternatively and preferably, the powders can by amorphous or irregular shaped for a draggy skin feel. When present, powders preferably comprise from about 0.01% to about 10%, preferably from about 0.1% to about 10%, more preferably from about 0.1% to about 5%, most preferably from about 0.4% to about 2% by weight of the composition. [0230]
  • iv.) Fluorochemicals
  • Also useful herein are fluorochemicals. These fluorochemicals include fluorotelemers, and perfluoropolyethers, some examples of which are described in Cosmetics & Toiletries, Using Fluorinated Compounds in Topical Preparations, Vol. 111, pages 47-62, (October 1996) which description is incorporated herein by reference. More specific examples of such liquid carriers include, but are not limited to, perfluoropolymethyl isopropyl ethers, perfluoropolypropylethers, acrylamide fluorinated telomer or mixtures thereof. Other more specific examples include, but are not limited to, the polyperfluoroisopropyl ethers available from Dupont Performance Chemicals under the trade name Fluortress ® PFPE oils. [0231]
  • When present, powders preferably comprise from about 0.01% to about 10%, preferably from about 0.1% to about 2% by weight of the composition. [0232]
  • Whilst some materials can function either as the lipophilic skin moisturizing agent, thickening agent therefor, or degreasing or detackifying agent, it will be appreciated that the moisturizing, thickening and degreasing or detackifying function cannot be provided by the same component. However, it will be understood that where the composition comprises three or more lipophilic skin moisturizing agents, two of said lipophilic skin moisturizing agents can also function as a thickening agent, or degreasing or detackifying agent. [0233]
  • Stabilizers
  • When a lipophilic skin moisturizing agent is employed as the mildness enhancer in the compositions herein, a stabilizer may also be included at a level ranging from about 0.1% to about 10%, preferably from about 0.1% to about 8%, more preferably from about 0.1% to about 5% by weight of the cleansing composition. [0234]
  • The stabilizer is used to form a crystalline stabilizing network in the liquid cleansing composition that prevents the lipophilic skin moisturizer agent droplets from coalescing and phase splitting in the product. The network exhibits time dependent recovery of viscosity after shearing (e.g., thixotropy). [0235]
  • The stabilizers used herein are not surfactants. The stabilizers provide improved shelf and stress stability. Some preferred hydroxyl-containing stabilizers include 12-hydroxystearic acid, 9,10-dihydroxystearic acid, tri-9,10-dihydroxystearin and tri-12-hydroxystearin (hydrogenated castor oil is mostly tri-12-hydroxystearin). Tri-12-hydroxystearin is most preferred for use in the compositions herein. When these crystalline, hydroxyl-containing stabilizers are utilized in the cleansing compositions herein, they are typically present at from about 0.1% to 10%, preferably from 0.1% to 8%, more preferably from 0.1% to about 5% of the cleansing compositions. The stabilizer is insoluble in water under ambient to near ambient conditions. [0236]
  • Alternatively, the stabilizer employed in the cleansing compositions herein can comprise a polymeric thickener. When polymeric thickeners as the stabilizer in the cleansing compositions herein, they are typically included in an amount ranging from about 0.01% to about 5%, preferably from about 0.3% to about 3%, by weight of the composition. The polymeric thickener is preferably an anionic, nonionic, cationic or hydrophobically modifier polymer selected from the group consisting of cationic polysaccharides of the cationic guar gum class with molecular weights of 1,000 to 3,000,000, anionic, cationic, and nonionic homopolymers derived from acrylic and/or methacrylic acid, anionic, cationic, and nonionic cellulose resins, cationic copolymers of dimethyldialkylammonium chloride, and acrylic acid, cationic homopolymers of dimethylalkylammonium chloride, cationic polyalklene and ethoxypolyalkylene imines, polyethylene glycol of molecular weight from 100,000 to 4,000,000, and mixtures thereof. Preferably, the polymer is selected from the group consisting of sodium polyacrylate, hydroxy ethyl cellulose, cetyl hydroxy ethyl Cellulose, and Polyquaternium 10. [0237]
  • Alternatively, the stabilizer employed in the cleansing compositions herein can comprise C10-C22 ethylene glycol fatty acid esters. C10-C22 ethylene glycol fatty acid esters can also desirably be employed in combination with the polymeric thickeners hereinbefore described. The ester is preferably a diester, more preferably a C14-C18 diester, most preferably ethylene glycol distearate. When C10-C22 ethylene glycol fatty acid esters are utilized as the stabilizer in the personal cleansing compositions herein, they are typically present at from about 3% to about 10%, preferably from about 5% to about 8%, more preferably from about 6% to about 8% of the personal cleansing compositions. [0238]
  • Another class of stabilizer which can be employed in the cleansing compositions of the present invention comprises dispersed amorphous silica selected from the group consisting of fumed silica and precipitated silica and mixtures thereof. As used herein the term “dispersed amorphous silica” refers to small, finely divided non-crystalline silica having a mean agglomerate particle size of less than about 100 microns. [0239]
  • Fumed silica, which is also known as arced silica, is produced by the vapor phase hydrolysis of silicon tetrachloride in a hydrogen oxygen flame. It is believed that the combustion process creates silicone dioxide molecules which condense to form particles. The particles collide, attach and sinter together. The result of this process is a three dimensional branched chain aggregate. Once the aggregate cools below the fusion point of silica, which is about 1710° C., further collisions result in mechanical entanglement of the chains to form agglomerates. Precipitated silicas and silica gels are generally made in aqueous solution. See, Cabot Technical Data Pamphlet TD-100 entitled “CAB-O-SIL® Untreated Fumed Silica Properties and Functions”, October 1993, and Cabot Technical Data Pamphlet TD-104 entitled “CAB-O-SIL® Fumed Silica in Cosmetic and Personal Care Products”, March 1992, both of which are herein incorporated by reference. [0240]
  • The fumed silica preferably has a mean agglomerate particle size ranging from about 0.1 microns to about 100 microns, preferably from about 1 micron to about 50 microns, and more preferably from about 10 microns to about 30 microns. The agglomerates are composed of aggregates which have a mean particle size ranging from about 0.01 microns to about 15 microns, preferably from about 0.05 microns to about 10 microns, more preferably from about 0.1 microns to about 5 microns and most preferably from about 0.2 microns to about 0.3 microns. The silica preferably has a surface area greater than 50 sq. m/gram, more preferably greater than about 130 sq. m./gram, most preferably greater than about 180 sq. m./gram. [0241]
  • When amorphous silicas are used as the stabilizer herein, they are typically included in the cleansing compositions at levels ranging from about 0.1% to about 10%, preferably from about 0.25% to about 8%, more preferably from about 0.5% to about 5%. [0242]
  • A fourth class of stabilizer which can be employed in the cleansing compositions of the present invention comprises dispersed smectite clay selected from the group consisting of bentonite and hectorite and mixtures thereof. Bentonite is a colloidal aluminum clay sulfate. See Merck Index, Eleventh Edition, 1989, entry 1062, p. 164, which is incorporated by reference. Hectorite is a clay containing sodium, magnesium, lithium, silicon, oxygen, hydrogen and flourine. See Merck Index, eleventh Edition, 1989, entry 4538, p. 729, which is herein incorporated by reference. [0243]
  • When smectite clay is employed as the stabilizer in the cleansing compositions of the present invention, it is typically included in amounts ranging from about 0.1% to about 10%, preferably from about 0.25% to about 8%, more preferably from about 0.5% to about 5%. [0244]
  • Other known stabilizers, such as fatty acids and fatty alcohols, can also be employed in the compositions herein. Palmitic acid and lauric acid are especially preferred for use herein. [0245]
  • Other Optional Ingedients
  • The compositions of the present invention can comprise a wide range of optional ingredients. The [0246] CTFA International Cosmetic Ingredient Dictionary, Sixth Edition, 1995, which is incorporated by reference herein in its entirety, describes a wide variety of nonlimiting cosmetic and pharmaceutical ingredients commonly used in the skin care industry, which are suitable for use in the compositions of the present invention. Nonlimiting examples of functional classes of ingredients are described at page 537 of this reference. Examples of these functional classes include: abrasives, anti-acne agents, anticaking agents, antioxidants, binders, biological additives, bulking agents, chelating agents, chemical additives, colorants, cosmetic astringents, cosmetic biocides, denaturants, drug astringents, emulsifiers, external analgesics, film formers, fragrance components, humectants, opacifying agents, plasticizers, preservatives, propellants, reducing agents, skin bleaching agents, skin-conditioning agents (emollient, humectants, miscellaneous, and occlusive), skin protectants, solvents, foam boosters, hydrotropes, solubilizing agents, suspending agents (nonsurfactant), sunscreen agents, ultraviolet light absorbers, and viscosity increasing agents (aqueous and nonaqueous). Examples of other functional classes of materials useful herein that are well known to one of ordinary skill in the art include solubilizing agents, sequestrants, and keratolytics, and the like.
  • Water-Insoluble Substrates
  • The compositions of the present invention can also be, optionally, incorporated into a insoluble substrate for application to the skin such as in the form of a treated wipe. Suitable water insoluble substrate materials and methods of manufacture are described in Riedel, “Nonwoven Bonding Methods and Materials,” [0247] Nonwoven World (1987); The Encyclopedia Americana, vol. 11, pp. 147-153, vol. 21, pp. 376-383, and vol. 26, pp. 566-581 (1984); U.S. Pat. No. 3,485,786 to Evans, issued Dec. 23, 1969;; U.S. Pat. No. 2,862,251, to Kalwarres; U.S. Pat. No. 3,025,585, Kalwarres; U.S. Pat. No. 4,891,227, to Thaman et al., issued Jan. 2, 1990; and U.S. Pat. No. 4,891,228 and U.S. Pat. No. 5,686,088 to Mitra et al., issued Nov. 11, 1997; U.S. Pat. No. 5,674,591; James et al; issued Oct. 7, 1997; all of which are herein incorporated by reference in their entirety.
  • Nonwoven substrates made from synthetic materials useful in the present invention can also be obtained from a wide variety of commercial sources. Nonlimiting examples of suitable nonwoven layer materials useful herein include PGI Miratec Herringbone, a patterned hydroentangled material containing about 30% rayon and 70% polyester, and having a basis weight of about 56 grams per square yard (gsy), available from PGI/Chicopee, Dayton N.J.; PGI Miratec Starburst, a patterned hydroentangled material containing about 30% rayon and 70% polyester, and having a basis weight of about 56 grams per square yard (gsy), available from PGI/Chicopee, Dayton N.J.; Novonet[0248] R 149-616, a thermo-bonded grid patterned material containing about 100% polypropylene, and having a basis weight of about 50 gsy, available from Veratec, Inc., Walpole, Mass. ; NovonetR 149-801, a thermo-bonded grid patterned material containing about 69% rayon, about 25% polypropylene, and about 6% cotton, and having a basis weight of about 75 gsy, available from Veratec, Inc. Walpole, Mass.; NovonetR 149-191, a thermo-bonded grid patterned material containing about 69% rayon, about 25% polypropylene, and about 6% cotton, and having a basis weight of about 100 gsy, available from Veratec, Inc. Walpole, Mass.; HEF NubtexR 149-801, a nubbed, apertured hydroentangled material, containing about 100% polyester, and having a basis weight of about 70 gsy, available from Veratec, Inc. Walpole, Mass.; KeybakR 951V, a dry formed apertured material, containing about 75% rayon, about 25% acrylic fibers, and having a basis weight of about 43 gsy, available from PGI/Chicopee, Dayton, N.J.; KeybakR 1368, an apertured material, containing about 75% rayon, about 25% polyester, and having a basis weight of about 39 gsy, available from PGI/Chicopee, Dayton, N.J.; DuralaceR 1236, an apertured, hydroentangled material, containing about 100% rayon, and having a basis weight from about 40 gsy to about 115 gsy, available from PGI/Chicopee, Dayton, N.J.; DuralaceR 5904, an apertured, hydroentangled material, containing about 100% polyester, and having a basis weight from about 40 gsy to about 115 gsy, available from PGI/Chicopee, Dayton, N.J.; Sontara 8877, an apertured hydroentangled material, containing about 50% Nylon and about 50% Pulp, and having a basis weight of about 68 gsm, available from Dupont Chemical Corp.
  • Alternatively, the water insoluble substrate can be a polymeric mesh sponge as described in U.S. Pat. No. 5,650,384, incorporated by reference herein in its entirety. The polymeric sponge comprises a plurality of plies of an extruded tubular netting mesh prepared from a strong flexible polymer, such as addition polymers of olefin monomers and polyamides of polycarboxylic acids. Although these polymeric sponges are designed to be used in conjunction with a liquid cleanser, these types of sponges can be used as the water insoluble substrate in the present invention. [0249]
  • Methods for Cleansing and Disinfecting the Skin
  • The skin cleansing compositions of the present invention are useful for disinfecting and cleansing the skin. Generally, the skin disinfection and cleansing process involves topically applying to the skin a safe and effective amount of a composition of the present invention. The present invention can be used when cleansing processes requiring soap and water are unavailable or inconvenient. The amount of the composition applied, the frequency of application and the period of use will vary widely depending upon the level of disinfection and cleansing desired, e.g., the degree of microbial contamination and/or skin soiling. Typical amounts of cleansing composition used preferably range from about 0.1 mg/cm[0250] 2 to about 20 mg/cm2, more preferably from about 0.5 mg/cm2 to about 10 mg/cm2, and most preferably about 1 mg/ cm2 to about 5 mg/cm2 of skin area to be cleansed. Preferably, the cleansing compositions of the present invention are used to cleanse and disinfect human and/or animal skin.
  • The present invention also encompasses the method of applying an effective amount of the cleansing compositions of the present invention onto non-skin surfaces, such as household surfaces, e.g., countertops, kitchen surfaces, food preparing surfaces (cutting boards, dishes, pots and pans, and the like); major household appliances, e.g., refrigerators, freezers, washing machines, automatic dryers, ovens, microwave ovens, dishwashers; cabinets; walls; floors; bathroom surfaces, shower curtains; garbage cans and/or recycling bins, and the like. [0251]
  • Article of Manufacture
  • The present invention also relates to an article of manufacture comprising a dispensing container containing the cleansing composition. Said dispensing container can be constructed of any of the conventional material employed in fabricating containers, including, but not limited to: polyethylene; polypropylene; polyacetal; polycarbonate; polyethyleneterephthalate; polyvinyl chloride; polystyrene; blends of polyethylene, vinyl acetate, and rubber elastomer. Other materials can include stainless steel and glass. A preferred container is made of clear material, e.g., polyethylene terephthalate. [0252]
  • Also preferred is an article of manufacture wherein the dispensing container is a spray dispenser. Said spray dispenser is any of the manually activated means for producing a spray of liquid droplets as is known in the art. A preferred spray container is made of clear material, e.g., polyethylene terephthalate. [0253]
  • Preparation of the Substrate Material Impregnated with Cleansing Composition
  • Any method suitable for the application of aqueous or aqueous/alcoholic impregnates, including flood coating, spray coating or metered dosing, can be used to impregnate the fibrous webs herein with the cleansing compositions described herein. More specialized techniques, such as Meyer Rod, floating knife or doctor blade, which are typically used to impregnate liquids into absorbent sheets may also be used. [0254]
  • The emulsion should preferably comprise from about 100% to about 400%, preferably from about 100% to about 300% by weight of the absorbent sheet. [0255]
  • After coating, the sheets may be folded into stacks and packaged in any of the moisture and vapor impermeable packages known in the art. [0256]
  • The anti-microbial cleansing compositions of the present invention are made via art recognized techniques for the various forms compositions. [0257]
  • Methods of Using the Cleansing Wipes
  • The cleansing compositions and wipe of the present invention are useful for personal cleansing, reducing germs on skin, and providing residual effectiveness versus microorganisms such as fungus and bacteria as well as viruses. Typically the wipe is used to apply the cleansing compositions to the area to be cleansed. The wipes herein can be used for personal cleansing when the use of cleansing products requiring water cannot be, or are inconvenient. Typical quantities of the present wipes useful for cleansing, range from about 1 to about 4 wipes per use, preferably from about 1 to about 2 wipes per use. Typical amounts of cleansing composition used range from about 4 mg/cm[0258] 2 to about 6 mg/cm2, preferably about 5 mg/cm2 of skin area to be cleansed.
  • EXAMPLES
  • The following examples further describe and demonstrate embodiments within the scope of the present invention. In the following examples, all ingredients are listed at an active level. The examples are given solely for the purpose of illustration and are not to be construed as limitations of the present invention, as many variations thereof are possible without departing from the spirit and scope of the invention. [0259]
  • Ingredients are identified by chemical or CTFA name. [0260]
  • Example 1
  • The following is an example of a water-insoluble substrate useful in the present invention. [0261]
  • A patterned hydroentangled non-woven substrate having a basis weight of 56 gms, comprising 70% polyester and 30% rayon approximately 6.5 inches wide by 7.5 inches long with a caliper of about 0.80 mm. Optionally, the substrate can be pre-coated with dimethicone (Dow Corning 200 Fluid 5cst) using conventional substrate coating techniques. [0262]
  • Example 2
  • An aqueous lotion was made based on the following composition: [0263]
    Ingredient Amount (weight percent)
    Cocamine Oxide (C10/C16 alkyl 0.5
    dimethyl amine oxide; AO-1214 LP
    supplied by Procter & Gamble Co.)
    Pyroglutamic Acid (pidolidone) 4
    (2-pyrrolidone-5 carboxylic acid)
    Ethanol - denatured 200 proof (SD 10
    alcohol 40)
    DC Antiform H-10 (dimethicone) 0.03
    Sodium Benzoate 0.2
    Tetrasodium EDTA (Hampene 220) 0.1
    Sodium Chloride 0.4
    Perfume 0.01
    Water and minors q.s.
    NaOH or HCl for pH adjustment to
    pH = 3.0
  • In a suitable container, the pyroglutamic acid, sodium chloride and water are added and mixed with stirring until mixture is homogeneous. Sodium benzoate, tetrasodium EDTA and cocamine oxide are then added to the mixture with stirring and mixed until the ingredients are completely dissolved. Once dissolved, the DC Antiform H-10 is added to the mixture with stirring. In a separate container, the perfume and ethanol are mixed to form a premix. The premix is then added to the cocamine oxide mixture to form the aqueous lotion. The aqueous lotion is pH adjusted to about 3.0 using NaOH or HCl. The aqueous lotion is applied to the skin in an appropriate amount to disinfect and cleanse the skin. [0264]
  • Alternatively, the aqueous lotion can be applied onto the substrate of Example 1 at a lotion to wipe weight ratio of about 2:1 using conventional substrate coating techniques for application to the skin as an antimicrobial and cleansing wipe. [0265]
  • Example 3
  • An aqueous lotion was made based on the following composition: [0266]
    Ingredient Amount (weight percent)
    Cocamine Oxide 0.5
    Pyroglutamic Acid 4
    (2-pyrrolidone-5 carboxylic acid)
    Ethanol 10
    DC Antiform H-10 0.03
    Sodium Benzoate 0.2
    Tetrasodium EDTA 0.1
    Sodium Chloride 0.4
    Tospearl 2000 2
    Perfume 0.01
    Water and minors q.s.
    NaOH or HCl for pH adjustment
    to pH = 3.0
  • In a suitable container, the pyroglutamic acid, sodium chloride and water are added and mixed with stirring until mixture is homogeneous. Sodium benzoate, tetrasodium EDTA and cocamine oxide are then added to the mixture with stirring and mixed until the ingredients are completely dissolved. Once dissolved, the DC Antiform H-10 is added to the mixture with stirring. In a separate container, the perfume and ethanol are mixed to form a premix. The premix is then added to the cocamine oxide mixture to form the aqueous lotion. Next, the Tospearl is added into the aqueous lotion with stirring until homogeneous. The aqueous lotion is pH adjusted to about 3.0 using NaOH or HCl. The aqueous lotion is applied to the skin in an appropriate amount to disinfect and cleanse the skin. [0267]
  • Alternatively, the aqueous lotion can be applied onto the substrate of Example 1 at a lotion to wipe weight ratio of about 2:1 using conventional substrate coating techniques for application to the skin as an antimicrobial and cleansing wipe. [0268]

Claims (12)

What is claimed is:
1. A cleansing composition, comprising:
(a) from about 0.01% to about 40% by weight of an amphoteric surfactant;
(b) from about 0.1% to about 20% by weight of 2-pyrrolidone-5 carboxylic acid; and
(c) from about 3% to about 99.89% by weight of an aqueous component,
wherein the cleansing composition has a pH in the range of about 2.0 to about 5.5.
2. A cleansing composition according to claim 1 wherein the amphoteric is selected from surfactant compounds of the following formulas:
Figure US20020172656A1-20021121-C00005
wherein R1 is an alkyl, alkenyl, aryl, or hydroxyalkyl radical of from about 8 to about 22 carbon atoms, optionally interrupted with up to about 10 ethylene oxide moieties and/or 1 glyceryl moiety, R2 and R3 are individually selected from alkyl and monohydroxyalkyl groups containing from about 1 to about 3 carbon atoms, R4 is alkylene, or hydroxyalkylene of from about 1 to about 4 carbon atoms, Z1 is a radical selected from carboxylate, sulfonate, sulfate, phosphate, or phosphonate, x is 0 or 1, n is from about 1 to about 6, and m is 0 or 1. Preferably, R1 is an alkyl, alkenyl, or hydroxyalkyl radical of from 11 to 17 carbon atoms, R2 and R3 are individually selected from alkyl groups containing of from 1 to 3 carbon atoms, R4 is alkylene or hydroxyalkylene of from 1 to 2 carbon atoms, Z1 is a radical selected from carboxylate, sulfonate, x is 0 or 1, n is 1 to 3, and m is 0 or 1;
Figure US20020172656A1-20021121-C00006
wherein R5 is C8-C22 alkyl, alkenyl, aryl, or hydroxyalkyl, preferably C8-C22, R6 is hydrogen or CH2CO2M1, R7 is CH2CH2OH or CH2CH2OCH2CH2COOM1, R8 is hydrogen, CH2CH2OH, or CH2CH2OCH2CH2COOM1, Z2 is CO2M1 or CH2CO2M1, y is 2 or 3, preferably 2, M1 is hydrogen or a cation, such as alkali metal, alkaline earth metal, ammonium, alkanol ammonium, sulfate, sulfonate, phosphate, or phosphonate;
R9—NH(CH2)aCOOM2   (III) R9—N[(CH2)aCOOM2]2   (IV)
wherein a is a number from 1 to 4, R9 is C8-C22 alkyl alkenyl, aryl, hydroxyalkyl or alkylamidoalkyls, and M2 is hydrogen, alkali metal, alkaline earth metal, ammonium or alkanolammonium;
Figure US20020172656A1-20021121-C00007
wherein R10 or R12 is methyl, ethyl, or hydroxyethyl, and R11 is C8-C22 alkyl, alkenyl, or aryl, or CH3(CH2)pCONH(CH2)q wherein p is 8-22 and q is 1-6. Preferably, R10 and R12 are methyl, R11 is C10-18 alkyl, alkenyl, p is 11-17, and q is 1-3.
3. A cleansing composition according to claim 2 wherein the amphoteric surfactant is selected from the group consisting of amide betaines, amide sulfo betaines, alkyl betaines, alkenyl betaines, sultaines (sulfo betaines), imidazolinium betaines, cocoamphocarboxypropionate, cocoamphocarboxypropionic acid, cocoamphocarboxy-glycinate, cocoamphoacetate, N-lauryl-beta-amino propionic acid, N-lauryl-beta-imino-dipopionic acid, amine oxides, tertiary phosphine oxides, dialkyl sulfoxides, salts thereof and mixtures thereof.
4. A cleansing composition according to claim 2 wherein the amphoteric surfactant has the following formula:
Figure US20020172656A1-20021121-C00008
wherein R10 or R12 is methyl, ethyl, or hydroxyethyl, and R11 is C8-C22 alkyl, alkenyl, or aryl, or CH3(CH2)pCONH(CH2)q wherein p is 8-22 and q is 1-6. Preferably, R10 and R12 are methyl, R11 is C10-18 alkyl, alkenyl, p is 11-17, and q is 1-3.
5. A cleansing composition according to claim 1 further comprising a mildness enhancer.
6. A cleansing composition according to claim 5 wherein the mildness enhancer is selected from the group consisting of cationic polymers, nonionic polymers, co-surfactants, moisturizers and mixtures thereof.
7. A cleansing composition according to claim 6 wherein the moisturizer is a lipid skin moisturizer.
8. A cleansing composition according to claim 7 wherein the lipid skin moisturizer is selected from the group consisting of hydrocarbon oils, hydrocarbon waxes, silicones, fatty acid derivatives, cholesterol, cholesterol derivatives, di- and tri-glycerides, vegetable oils, vegetable oil derivatives, liquid nondigestible oils, blends of liquid digestible or nondigestible oils with solid polyol polyesters, acetoglyceride esters, alkyl esters, alkenyl esters, lanolin and its derivatives, milk tri-glycerides, wax esters, beeswax derivatives, sterols, phospholipids and mixtures thereof.
9. A cleansing composition according to claim 8 wherein the lipid skin moisturizer is petrolatum.
10. A cleansing wipe, comprising:
(a) one or more layers of water-insoluble substrate; and
(b) a safe and effective amount of a cleansing wipe composition comprising:
i.) from about 0.01% to about 40% of an amphoteric surfactant by weigh of the cleansing wipe composition;
ii.) from about 0.1% to about 20% by weight of 2-pyrrolidone-5 carboxylic acid by weight of the cleansing wipe composition; and
iii.) from about 3% to about 99.89% of an aqueous component by weight of the cleansing wipe composition,
wherein the composition has a pH in the range of about 2.0 to about 5.5.
11. A method for cleansing skin comprising the applying a safe and effective amount of the composition of claim 1 on mammalian skin.
12. A method for cleansing skin comprising the applying the cleansing wipe of claim 10 on mammalian skin.
US09/738,375 2000-01-20 2000-12-15 Cleansing compositions Abandoned US20020172656A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US09/738,375 US20020172656A1 (en) 2000-01-20 2000-12-15 Cleansing compositions

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US17709100P 2000-01-20 2000-01-20
US17709200P 2000-01-20 2000-01-20
US19193900P 2000-03-24 2000-03-24
US09/738,375 US20020172656A1 (en) 2000-01-20 2000-12-15 Cleansing compositions

Publications (1)

Publication Number Publication Date
US20020172656A1 true US20020172656A1 (en) 2002-11-21

Family

ID=27390775

Family Applications (2)

Application Number Title Priority Date Filing Date
US09/738,375 Abandoned US20020172656A1 (en) 2000-01-20 2000-12-15 Cleansing compositions
US09/738,365 Expired - Fee Related US6436885B2 (en) 2000-01-20 2000-12-15 Antimicrobial cleansing compositions containing 2-pyrrolidone-5-carboxylic acid

Family Applications After (1)

Application Number Title Priority Date Filing Date
US09/738,365 Expired - Fee Related US6436885B2 (en) 2000-01-20 2000-12-15 Antimicrobial cleansing compositions containing 2-pyrrolidone-5-carboxylic acid

Country Status (3)

Country Link
US (2) US20020172656A1 (en)
AU (2) AU2001231045A1 (en)
WO (2) WO2001052811A1 (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060058210A1 (en) * 2004-09-15 2006-03-16 The Procter & Gamble Company Wet wipe lotions comprising particulate material
WO2006088818A1 (en) * 2005-02-15 2006-08-24 Georgia Tech Research Corporation Method for altering the tack of materials
US20070017553A1 (en) * 2005-05-04 2007-01-25 Neplenbroek Antonius M Warewashing system containing low levels of surfactant
US20080149288A1 (en) * 2006-02-14 2008-06-26 Georgia Tech Research Corporation Method for Altering the Tack of Materials
EP1974715A1 (en) * 2007-03-31 2008-10-01 Zschimmer & Schwarz GmbH & Co KG Chemische Fabriken Liquid composition for impregnating wet wipes
US20090117055A1 (en) * 2006-06-16 2009-05-07 Hwa Jeong Ryu Disinfectant having ozone
US20110232691A1 (en) * 2008-12-02 2011-09-29 Diversey, Inc. Ware washing system containing cationic starch
US8647444B2 (en) 2007-07-05 2014-02-11 Diversey, Inc. Rinse aid
DE10296678B4 (en) * 2001-04-18 2014-03-27 Kimberly-Clark Worldwide, Inc. Anionic carboxymethylcellulose particle-containing skin cleansing composition
US8785367B2 (en) * 2012-12-12 2014-07-22 Lec, Inc. Cleansing sheet
US8815791B2 (en) 2008-12-02 2014-08-26 Diversey, Inc. Cleaning of a cooking device or appliance with a composition comprising a built-in rinse aid

Families Citing this family (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6759434B2 (en) 1999-09-22 2004-07-06 B. Ron Johnson Anti-infective compositions, methods and systems for treating disordered tissue
US8173709B2 (en) * 1999-09-22 2012-05-08 Quadex Pharmaceuticals, Llc Anti-infective methods for treating pathogen-induced disordered tissues
WO2002007701A2 (en) * 2000-07-24 2002-01-31 The Procter & Gamble Company Wet wipes
WO2003018732A1 (en) * 2001-08-24 2003-03-06 The Clorox Company Improved cleaning composition
US6530382B2 (en) * 2001-06-06 2003-03-11 Basf Corporation Gel purge formulations and methods of cleaning extruders by using the same
FR2826270B1 (en) * 2001-06-22 2005-01-28 Oreal WIPES AND USES IN THE COSMETIC FIELD
US6497894B1 (en) * 2001-08-06 2002-12-24 Dow Corning Corporation Aqueous dispersion of cured silicone rubber particles
MXPA04003307A (en) * 2001-10-09 2004-07-23 Procter & Gamble Pre-moistened wipe for treating a surface.
US6884763B2 (en) * 2001-10-30 2005-04-26 Permatex, Inc. Waterless hand cleaner containing plant derived natural essential oil
CA2480330C (en) * 2002-03-28 2011-05-03 Council Of Scientific & Industrial Research Composition and process for preparing herbal disinfectants and their use
US20030194425A1 (en) * 2002-04-11 2003-10-16 L'oreal Moist cleansing, skin care or cosmetic article
US7008979B2 (en) 2002-04-30 2006-03-07 Hydromer, Inc. Coating composition for multiple hydrophilic applications
US8012495B2 (en) * 2002-05-07 2011-09-06 Georgia-Pacific Consumer Products Lp Lotion-treated tissue and towel
US7169400B2 (en) * 2002-05-07 2007-01-30 Fort James Corporation Waterless lotion and lotion-treated substrate
US20060189497A1 (en) * 2002-07-30 2006-08-24 Earl Jenevein Wood preservative
US7045492B2 (en) * 2002-07-30 2006-05-16 Earl Jenevein Cleaning composition comprising cationic surfactants, chelant, and an alcohol solvent mixture
US6511950B1 (en) * 2002-07-30 2003-01-28 Earl Jenevein Cleaning composition comprising a salt, chelant, and polyvinyl alcohol
WO2004022022A1 (en) * 2002-09-03 2004-03-18 Jerzy Hubert Edward Dangel A topical composition for treatment of skin disorders
US6951833B2 (en) * 2002-09-17 2005-10-04 O'neil Deborah Anti-microbial compositions
US20040202614A1 (en) * 2003-03-07 2004-10-14 Roger Davis Utensil spray composition and portable aerosol device and method therefor
US7488757B2 (en) 2003-03-24 2009-02-10 Becton, Dickinson And Company Invisible antimicrobial glove and hand antiseptic
US6875453B2 (en) * 2003-07-18 2005-04-05 Manuel Viamonte, Jr. Non-toxic disinfectant containing a isopropyl alcohol and sesame oil composition with lemon oil and menthol
US7651989B2 (en) 2003-08-29 2010-01-26 Kimberly-Clark Worldwide, Inc. Single phase color change agents
ITMI20040244A1 (en) * 2004-02-13 2004-05-13 Vama Farmacosmetica S R L BACTERIOSTATIC SUBSTANCE FOR PREPARATIONS FOR TOPICAL USE, IN PARTICULAR FOR DERMOPHARMACEUTICAL AND COSMETIC USE AND PREPARATIONS INCLUDING THIS SUBSTANCE
ATE406180T1 (en) * 2004-10-13 2008-09-15 Procter & Gamble DEVICE FOR DELIVERING AN ANTIMICROBIAL COMPOSITION
US20060121098A1 (en) * 2004-11-15 2006-06-08 Mendoza Randall P Dermal defense system and method of use
US20080199535A1 (en) * 2004-12-09 2008-08-21 The Dial Corporation Compositions Having a High Antiviral and Antibacterial Efficacy
RU2380099C2 (en) * 2004-12-09 2010-01-27 Дзе Дайл Корпорэйшн Compositions with high antiviral and antibacterial efficiency
US20090012174A1 (en) * 2004-12-09 2009-01-08 The Dial Corporation Compositions Having a High Antiviral and Antibacterial Efficacy
CA2589281A1 (en) * 2004-12-09 2006-06-15 The Dial Corporation Compositions having a high antiviral and antibacterial efficacy
MX2007006864A (en) * 2004-12-09 2008-02-15 Dial Corp Compositions having a high antiviral and antibacterial efficacy.
US7803746B2 (en) * 2004-12-16 2010-09-28 Georgia-Pacific Consumer Products Lp Antimicrobial foam hand soap comprising inulin or an inulin surfactant
US7521404B2 (en) 2004-12-16 2009-04-21 Georgia-Pacific Consumer Products Lp Antimicrobial liquid hand soap composition with tactile signal comprising a phospholipid surfactant
US7148187B1 (en) 2005-06-28 2006-12-12 The Clorox Company Low residue cleaning composition comprising lactic acid, nonionic surfactant and solvent mixture
US20060293214A1 (en) * 2005-06-28 2006-12-28 Lily Cheng Synergistic acidic ternary biocidal compositions
US20070142262A1 (en) * 2005-12-15 2007-06-21 Kimberly-Clark Worldwide, Inc. Bacteria capturing treatment for fibrous webs
WO2007075681A1 (en) * 2005-12-19 2007-07-05 Hercules Incorporated Chemically-enhanced mechanical treatment of water
US9629361B2 (en) 2006-02-09 2017-04-25 Gojo Industries, Inc. Composition and method for pre-surgical skin disinfection
US8450378B2 (en) * 2006-02-09 2013-05-28 Gojo Industries, Inc. Antiviral method
US20070185216A1 (en) * 2006-02-09 2007-08-09 Marcia Snyder Antiviral method
US8119115B2 (en) * 2006-02-09 2012-02-21 Gojo Industries, Inc. Antiviral method
US8388992B2 (en) 2006-03-28 2013-03-05 Georgia-Pacific Consumer Products Lp Anti-microbial hand towel with time-delay chromatic transfer indicator and absorbency rate delay
US20070274926A1 (en) * 2006-05-26 2007-11-29 The Dial Corporation Method of inhibiting the transmission of viruses
EP2040542A2 (en) 2006-05-30 2009-04-01 The Dial Corporation Compositions having a high antiviral effeicacy
CA2653347A1 (en) * 2006-05-31 2007-12-13 The Dial Corporation Alcohol-containing antimicrobial compositions having improved efficacy
US8337872B2 (en) 2006-06-02 2012-12-25 The Dial Corporation Method of inhibiting the transmission of influenza virus
RU2008152442A (en) * 2006-06-05 2010-07-20 Дзей Дайл Корпорейшн (Us) METHODS AND PRODUCTS HAVING HIGH ANTIVIRAL AND ANTI-BACTERIAL EFFICIENCY
US20080275113A1 (en) * 2007-05-04 2008-11-06 Thomas Edward Huetter Antimicrobial Compositions, Products, And Methods Of Use
US20090035340A1 (en) * 2007-07-30 2009-02-05 Kimberly-Clark Worldwide, Inc. Preservative compositions for moist wipes
US8871807B2 (en) 2008-03-28 2014-10-28 Ecolab Usa Inc. Detergents capable of cleaning, bleaching, sanitizing and/or disinfecting textiles including sulfoperoxycarboxylic acids
US12203056B2 (en) 2008-03-28 2025-01-21 Ecolab Usa Inc. Sulfoperoxycarboxylic acids, their preparation and methods of use as bleaching and antimicrobial agents
US8809392B2 (en) 2008-03-28 2014-08-19 Ecolab Usa Inc. Sulfoperoxycarboxylic acids, their preparation and methods of use as bleaching and antimicrobial agents
EP2271616B1 (en) 2008-03-28 2020-11-11 Ecolab USA Inc. Sulfoperoxycarboxylic acids, their preparation and methods of use as bleaching and antimicrobial agents
CA2739843C (en) * 2008-10-20 2018-01-09 Unilever Plc Antimicrobial composition comprising thymol and terpineol for disinfecting surfaces
IL295075A (en) * 2009-05-06 2022-09-01 Laboratory Skin Care Inc Preparations for administration through the skin that include complexes of an active substance with calcium phosphate and methods of using them
MX2012003563A (en) 2009-09-24 2012-04-30 Unilever Nv DISINFECTING AGENT UNDERSTANDING EUGENOL, TERPINEOL AND TIMOL.
EP2536387A2 (en) * 2010-02-17 2012-12-26 The Procter & Gamble Company Non-aerosol personal care compositions comprising an anti-irritation agent
US8575084B2 (en) 2010-11-12 2013-11-05 Jelmar, Llc Hard surface cleaning composition for personal contact areas
US8569220B2 (en) 2010-11-12 2013-10-29 Jelmar, Llc Hard surface cleaning composition
EP2648681B1 (en) 2010-12-07 2015-01-07 Unilever N.V. An oral care composition
EP2773315B1 (en) 2011-11-03 2015-07-08 Unilever N.V. A personal cleaning composition
US9321664B2 (en) 2011-12-20 2016-04-26 Ecolab Usa Inc. Stable percarboxylic acid compositions and uses thereof
US20130260625A1 (en) * 2012-03-09 2013-10-03 Jr Chem Llc Method and device for lint removal in clothes dryers
US10017403B2 (en) 2012-03-30 2018-07-10 Ecolab Usa Inc. Use of peracetic acid/hydrogen peroxide and peroxide-reducing enzymes for treatment of drilling fluids, frac fluids, flowback water and disposal water
US9434910B2 (en) 2013-01-16 2016-09-06 Jelmar, Llc Mold and mildew stain removing solution
US9873854B2 (en) 2013-01-16 2018-01-23 Jelmar, Llc Stain removing solution
US10165774B2 (en) 2013-03-05 2019-01-01 Ecolab Usa Inc. Defoamer useful in a peracid composition with anionic surfactants
US8822719B1 (en) 2013-03-05 2014-09-02 Ecolab Usa Inc. Peroxycarboxylic acid compositions suitable for inline optical or conductivity monitoring
US20140256811A1 (en) 2013-03-05 2014-09-11 Ecolab Usa Inc. Efficient stabilizer in controlling self accelerated decomposition temperature of peroxycarboxylic acid compositions with mineral acids
US9549930B2 (en) 2013-03-14 2017-01-24 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered and/or prodromal stage tissue
US9125911B2 (en) 2013-03-14 2015-09-08 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered tissues
US9463180B2 (en) 2013-03-14 2016-10-11 Quadex Pharmaceuticals, Llc Treatment of molluscum contagiosum
GB2517778B (en) 2013-09-02 2015-08-05 Robert Anthony William Scoones Cleaning liquid
CN104173248B (en) * 2014-09-05 2017-05-10 南京市清泫堂生物科技有限公司 Natural plant essential oil-containing disinfecting liquid soap, as well as preparation method and application thereof
WO2018031067A1 (en) 2016-08-11 2018-02-15 Ecolab Usa Inc. Interaction between antimicrobial quaternary compounds and anionic surfactants
WO2018075089A1 (en) * 2016-10-21 2018-04-26 Ecolab Usa Inc. REDUCED INHALATION HAZARD OF QUATERNARY AMMONIUM COMPOUNDS-pH DRIVEN PHYSIOLOGICAL RESPONSE
AU2018333058A1 (en) 2017-09-15 2020-03-12 Gojo Industries, Inc. Antimicrobial composition
ES2991988T3 (en) 2017-10-30 2024-12-05 Takeda Pharmaceuticals Co Environmentally compatible detergents for the inactivation of lipid-enveloped viruses
CN113286583A (en) 2018-07-31 2021-08-20 金伯利-克拉克环球有限公司 Compositions comprising antimicrobial enhancers including sulfobetaines and methods of increasing the antimicrobial efficacy of compositions
AU2018434917B2 (en) * 2018-07-31 2024-07-11 Kimberly-Clark Worldwide, Inc. Composition including an antimicrobial boosting agent including an amphocarboxylate and methods of increasing the antimicrobial effectiveness of a composition
WO2020041545A1 (en) 2018-08-22 2020-02-27 Ecolab Usa Inc. Hydrogen peroxide and peracid stabilization with molecules based on a pyridine carboxylic acid at c-3, -4 or -5
US20220324796A1 (en) * 2019-06-12 2022-10-13 The General Hospital Corporation Antibiotic compounds
US12096768B2 (en) 2019-08-07 2024-09-24 Ecolab Usa Inc. Polymeric and solid-supported chelators for stabilization of peracid-containing compositions
CN112294699B (en) * 2020-11-04 2023-05-16 佛山市思怡诺生物科技有限公司 Low-irritation and foam-rich bath foam and preparation method thereof
US12023399B2 (en) 2021-06-30 2024-07-02 The Procter & Gamble Company Cleansing composition with pyrrolidone carboxylic acid
US12357551B2 (en) 2022-05-23 2025-07-15 The Procter & Gamble Company Antibacterial cleansing composition, uses and methods

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3141821A (en) 1959-03-17 1964-07-21 Lehn & Fink Products Corp Synergistic combination of alkyl sulfonates, alkylaryl sulfonates and topical antibacterial agents for local antisepsis
US4738984A (en) 1973-04-02 1988-04-19 Merrell Dow Pharmaceuticals Inc. Antirhinovirus agents
US4602099A (en) 1973-04-02 1986-07-22 Merrell Dow Pharmaceuticals Inc. Antirhinovirus agents
DE2402730A1 (en) * 1973-12-21 1975-07-03 Ciba Geigy Ag CLEANING ITEMS FOR USE IN THE BATHROOM OR UNDER THE SHOWER
US3969258A (en) 1974-10-10 1976-07-13 Pennwalt Corporation Low foaming acid-anionic surfactant sanitizer compositions
US4075350A (en) 1975-12-18 1978-02-21 Michaels Edwin B Antimicrobial compositions employing certain betaines and certain amine oxides
JPS5935361B2 (en) 1976-10-21 1984-08-28 カネボウ株式会社 skin lotion composition
DE2828724A1 (en) 1978-06-30 1980-01-10 Schuelke & Mayr Gmbh DISINFECTING CLOTH
US4767788A (en) 1978-08-14 1988-08-30 Sterling Drug Inc. Glutaric acid virucidal processes and compositions
EP0037224A1 (en) 1980-03-24 1981-10-07 THE PROCTER & GAMBLE COMPANY Rare earth metal carboxylates, their use as antimicrobial agents, and medicinal, cosmetic and cleansing compositions containing them
EP0049354A3 (en) 1980-09-08 1983-02-23 Sterling Drug Inc. Composition for therapeutic virucidal use, and articles and packages containing said composition
US4897304A (en) 1981-07-20 1990-01-30 Kimberly-Clark Corporation Virucidal composition, the method of use and the product therefor
US4828912A (en) 1981-07-20 1989-05-09 Kimberly-Clark Corporation Virucidal product having virucidal and/or germicidal properties
US4975217A (en) 1981-07-20 1990-12-04 Kimberly-Clark Corporation Virucidal composition, the method of use and the product therefor
US4597975A (en) 1981-11-06 1986-07-01 Woodward Fred E Iodine surface active compositions
US4738847A (en) 1985-01-14 1988-04-19 Kimberly-Clark Corporation Multi-ply virucidal product
DE3543801A1 (en) 1985-12-12 1987-06-25 Marquardt Bernd PHARMACEUTICAL PRODUCT CONTAINING A MIXTURE OF BENZOESIC ACID, PHENOL AND AN ALKALIFLUORIDE IN AQUEOUS OR AQUEOUS ALCOHOLIC SOLUTION AND ITS USE
US4824689A (en) 1986-02-28 1989-04-25 Kimberly-Clark Corporation Method for producing virucidal tissue products containing water-soluble humectants
US4764418A (en) 1986-02-28 1988-08-16 Kimberly-Clark Corporation Virucidal tissue products containing water-soluble humectants
US4891216A (en) 1987-04-14 1990-01-02 Alcide Corporation Disinfecting compositions and methods therefor
GB8811408D0 (en) * 1988-05-13 1988-06-15 Unilever Plc Cosmetic composition
DE3832799A1 (en) 1988-09-25 1990-03-29 Huang Tzong Chou Prof Dr APPLICATION OF ACETYLSALICYL ACID AND RELATED COMPOUNDS FOR THE DIRECT FIGHTING OF VIRUSES AND RELATED DISEASES
FR2656523B1 (en) 1989-12-29 1992-05-07 Biorga Sa Labo COMPOSITIONS FOR COSMETIC AND / OR DERMATOLOGICAL USE, INCLUDING METAL PIDOLATES.
US5098716A (en) 1990-08-23 1992-03-24 Embro William J Method and composition for treating diseases having a viral etiology
US5143720A (en) 1990-11-28 1992-09-01 Microcide, Inc. Disinfecting and sanitizing compositions
DE4137544C2 (en) 1991-11-12 1998-07-30 Kramer Axel Antimicrobial combination of active ingredients based on oxygen-releasing compounds
AU4538893A (en) 1992-06-16 1994-01-04 Embro Research Corporation Treatment for cutaneous pain, itching and inflammation with topical stannous fluoride
ES2091015T3 (en) * 1992-09-29 1996-10-16 Henkel Kgaa AGENT FOR HAIR TREATMENT.
JP3686434B2 (en) * 1993-10-01 2005-08-24 千寿製薬株式会社 Stabilizing method for contact lenses
JPH07157415A (en) 1993-12-03 1995-06-20 Shiseido Co Ltd Hair cosmetic
US5830487A (en) 1996-06-05 1998-11-03 The Procter & Gamble Company Anti-viral, anhydrous, and mild skin lotions for application to tissue paper products
US5681802A (en) 1994-06-01 1997-10-28 Lever Brothers Company, Division Of Conopco, Inc. Mild antimicrobial liquid cleansing formulations comprising buffering compound or compounds as potentiator of antimicrobial effectiveness
US6071866A (en) 1994-06-01 2000-06-06 Lever Brothers Company, Division Of Conopco, Inc. Mild antimicrobial liquid cleansing formulations comprising hydroxy acid buffering compound or compounds as potentiator of antimicrobial effectiveness
US5914300A (en) 1994-06-01 1999-06-22 Lever Brothers Company Mild antimicrobial liquid cleansing formulations comprising hydroxy acid buffering compound or compounds as potentiator of antimicrobial effectiveness
JP4098358B2 (en) 1994-06-20 2008-06-11 ユニリーバー・ナームローゼ・ベンノートシヤープ Improvements in antimicrobial cleaning compositions
CA2151774C (en) 1994-06-27 1999-04-06 Minh Quang Hoang Skin disinfecting formulations
SE9403541L (en) 1994-10-14 1996-04-15 Sven Moberg Antimicrobial composition
JPH08133911A (en) * 1994-11-04 1996-05-28 Senju Pharmaceut Co Ltd Antimicrobial composition
DE19504914C1 (en) * 1995-02-15 1995-11-16 Goldwell Gmbh shampoo
FR2743813B1 (en) 1996-01-23 1998-02-20 Oreal STABLE GEL COMPOSITION WITH HIGH ELECTROLYTE CONTENT
US5658946A (en) 1996-05-29 1997-08-19 The Procter & Gamble Company Methods for the treatment of herpes virus infections
BR9709422A (en) 1996-06-04 1999-08-10 Ciba Sc Holding Ag Concentrated liquid formulations comprising an active microbicidal ingredient
BR9712993A (en) 1996-10-22 2000-04-18 Procter & Gamble Oral compositions containing stannous gluconate.
US5897891A (en) 1996-11-18 1999-04-27 Godfrey; John C. Flavorful zinc compositions for oral use incorporating copper
AU7604498A (en) 1997-06-04 1998-12-21 Procter & Gamble Company, The Mild, antimicrobial wipes
US6183763B1 (en) 1997-06-04 2001-02-06 Procter & Gamble Company Antimicrobial wipes which provide improved immediate germ reduction
US6217887B1 (en) 1997-06-04 2001-04-17 The Procter & Gamble Company Leave-on antimicrobial compositions which provide improved immediate germ reduction
US6197315B1 (en) 1997-06-04 2001-03-06 Procter & Gamble Company Antimicrobial wipes which provide improved residual benefit versus gram negative bacteria
AU745392B2 (en) 1997-06-04 2002-03-21 Procter & Gamble Company, The Mild, leave-on antimicrobial compositions
JPH11263995A (en) 1998-03-18 1999-09-28 Shiseido Co Ltd Detergent composition
KR100450333B1 (en) 1998-04-24 2004-10-01 더 프록터 앤드 갬블 캄파니 Cleansing articles for skin and/or hair which also deposits skin care actives
US6413529B1 (en) 1999-04-13 2002-07-02 The Procter & Gamble Company Antimicrobial wipes which provide improved residual benefit versus gram negative bacteria
BR0014778A (en) 1999-10-19 2002-07-16 Procter & Gamble Antimicrobial Composition, Processes for Killing Bacteria, for Disabling Viruses, for Improving a Mammal's Global Health, for Reducing Absence of Persons, Use of Composition, Antimicrobial Product, and Personal Antimicrobial Treatment Set

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10296678B4 (en) * 2001-04-18 2014-03-27 Kimberly-Clark Worldwide, Inc. Anionic carboxymethylcellulose particle-containing skin cleansing composition
US20060058210A1 (en) * 2004-09-15 2006-03-16 The Procter & Gamble Company Wet wipe lotions comprising particulate material
US7977301B2 (en) * 2004-09-15 2011-07-12 The Procter & Gamble Company Wet wipe lotions comprising particulate material
US7666827B2 (en) * 2004-09-15 2010-02-23 The Procter & Gamble Company Wet wipe lotions comprising particulate material
US20100105593A1 (en) * 2004-09-15 2010-04-29 Randall Glenn Marsh Wet Wipe Lotions Comprising Particulate Material
AU2006214458B2 (en) * 2005-02-15 2011-06-02 Georgia Tech Research Corporation Method for altering the tack of materials
WO2006088818A1 (en) * 2005-02-15 2006-08-24 Georgia Tech Research Corporation Method for altering the tack of materials
US20080135194A1 (en) * 2005-02-15 2008-06-12 Georgia Tech Research Corporation Method for Improving the Consolidation and Dewatering of Suspended Particulate Matter
US7718075B2 (en) 2005-02-15 2010-05-18 Georgia Tech Research Corporation Method for improving the consolidation and dewatering of suspended particulate matter
US20070017553A1 (en) * 2005-05-04 2007-01-25 Neplenbroek Antonius M Warewashing system containing low levels of surfactant
US8876982B2 (en) 2005-05-04 2014-11-04 Diversey, Inc. Warewashing method using a cleaning composition containing low levels of surfactant
US8512523B2 (en) 2006-02-14 2013-08-20 Georgia Tech Research Corporation Method for altering the tack of materials
US20080149288A1 (en) * 2006-02-14 2008-06-26 Georgia Tech Research Corporation Method for Altering the Tack of Materials
US20090117055A1 (en) * 2006-06-16 2009-05-07 Hwa Jeong Ryu Disinfectant having ozone
US20080241204A1 (en) * 2007-03-31 2008-10-02 Zschimmer & Schwarz Gmbh & Co. Kg Wetting solution for wet wipes for cosmetic, personal hygiene, dermatological and/or cleaning purposes
EP1974715A1 (en) * 2007-03-31 2008-10-01 Zschimmer & Schwarz GmbH & Co KG Chemische Fabriken Liquid composition for impregnating wet wipes
US8647444B2 (en) 2007-07-05 2014-02-11 Diversey, Inc. Rinse aid
US20110232691A1 (en) * 2008-12-02 2011-09-29 Diversey, Inc. Ware washing system containing cationic starch
US8343286B2 (en) 2008-12-02 2013-01-01 Diversey, Inc. Ware washing system containing cationic starch
US8815791B2 (en) 2008-12-02 2014-08-26 Diversey, Inc. Cleaning of a cooking device or appliance with a composition comprising a built-in rinse aid
US8785367B2 (en) * 2012-12-12 2014-07-22 Lec, Inc. Cleansing sheet

Also Published As

Publication number Publication date
WO2001053443A1 (en) 2001-07-26
WO2001052811A1 (en) 2001-07-26
US6436885B2 (en) 2002-08-20
AU2001236496A1 (en) 2001-07-31
AU2001231045A1 (en) 2001-07-31
US20020002124A1 (en) 2002-01-03

Similar Documents

Publication Publication Date Title
US6436885B2 (en) Antimicrobial cleansing compositions containing 2-pyrrolidone-5-carboxylic acid
US20020098159A1 (en) Antimicrobial compositions
US6258368B1 (en) Antimicrobial wipes
CA2291743C (en) Leave-on antimicrobial compositions
US6190674B1 (en) Liquid antimicrobial cleansing compositions
US6113933A (en) Mild, rinse-off antimicrobial liquid cleansing compositions containing acidic surfactants
US6106851A (en) Mild, rinse-off antimicrobial liquid cleansing compositions containing salicyclic acid
US6488943B1 (en) Antimicrobial wipes which provide improved immediate germ reduction
US6413529B1 (en) Antimicrobial wipes which provide improved residual benefit versus gram negative bacteria
US6183763B1 (en) Antimicrobial wipes which provide improved immediate germ reduction
US6197315B1 (en) Antimicrobial wipes which provide improved residual benefit versus gram negative bacteria
EP0996422A1 (en) Mild, rinse-off antimicrobial liquid cleansing compositions
EP0984769A1 (en) Mild, antimicrobial wipes
WO1998055095A1 (en) Liquid antimicrobial cleansing compositions which provide residual benefit versus gram negative bacteria
CA2291249C (en) Mild, leave-on antimicrobial compositions

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO PAY ISSUE FEE